Rank,Term name,P-value,Z-score,Combined score,Overlapping genes,Adjusted p-value,Old p-value,Old adjusted p-value,gene count
1,miRNAs involved in DNA damage response WP1545,0.00040824813175030175,6.6687370600414075,52.04039261079248,"['RAD52', 'CCND3', 'CDKN1B', 'CDK6', 'CCND1', 'CCNE1', 'MYC', 'ABL1', 'ATM']",0.21539123953749856,0,0,9
2,Histone Modifications WP2369,0.0008024285836189313,2.8620382732532264,20.400230162068635,"['SETD5', 'KMT2D', 'SETD2', 'KMT2A', 'EED', 'SETD6', 'KMT2C', 'KMT2B', 'SETD1A', 'H3F3A', 'SETDB2', 'EHMT1', 'ASH1L', 'SETBP1', 'AEBP2', 'NSD1', 'SMYD1', 'KMT5B']",0.21539123953749856,0,0,18
3,Mesodermal commitment pathway WP2857,0.0011416496795273775,1.9348113456962648,13.108890501276656,"['TRIM71', 'SETD2', 'BMPR2', 'CTBP2', 'MBTD1', 'EPB41L5', 'CCND1', 'UBR5', 'CEP250', 'DIP2A', 'KDM6A', 'SMAD2', 'SMAD4', 'ATP8B2', 'TET1', 'TBX6', 'ELP4', 'TRERF1', 'EMSY', 'PBX1', 'ACVR2A', 'PARP8', 'LATS1', 'EXT2', 'CCDC88A', 'MEIS1', 'KLF5', 'DDAH1', 'AEBP2', 'BHLHE40', 'RARB', 'PLCH1', 'WDFY2', 'TOX', 'AHDC1', 'BMPR1A']",0.21539123953749856,0,0,36
4,Cytosine methylation WP3585,0.0019470075372284771,8.884522578421235,55.45240723073594,"['MECP2', 'MBD3', 'DNMT1', 'IDH1', 'TET2', 'TET1']",0.27550156651782953,0,0,6
5,MECP2 and Associated Rett Syndrome WP3584,0.004979502120780756,2.1244093744093746,11.264522160351799,"['GRIA1', 'MPP1', 'RBFOX1', 'GRID1', 'DHX9', 'HDAC1', 'RPS6', 'TET2', 'TET1', 'CTCF', 'IGF1', 'SMC3', 'MYT1', 'MECP2', 'FUT8', 'NCOR1', 'SP1', 'NF1', 'SGK1', 'GRIA3', 'CDON']",0.5636796400723816,0,0,21
6,Type II diabetes mellitus WP1584,0.0072439841901727805,4.442413793103448,21.890366779259214,"['IKBKB', 'SURF1', 'MAPK8', 'INSR', 'CACNA1A', 'PHKA2', 'SOCS4']",0.6096755100231704,0,0,7
7,Glycolysis in senescence WP5049,0.007641558812244703,5.329886246122027,25.97868457310315,"['RB1', 'PRKAA1', 'PKM', 'ALDOC', 'ENO1', 'GAPDH']",0.6096755100231704,0,0,6
8,Fragile X Syndrome  WP4549,0.009595631566837518,1.6968612836438923,7.884376579399676,"['GRIA1', 'SH3GL3', 'GABRB2', 'ABCD3', 'KCNC1', 'ITPR1', 'AP2A1', 'PIK3CB', 'SLC6A1', 'GPHN', 'GRM1', 'MECP2', 'RPTOR', 'PPP3CA', 'GRIN2A', 'CNR1', 'MKNK1', 'FYN', 'EIF4E', 'SH3GL1', 'DICER1', 'GRIN2B', 'DNM2', 'ALDH3A2', 'ARHGAP32', 'RPS6KB1', 'AGO2', 'NF1', 'KRAS', 'RAF1', 'EIF4G1', 'HCN1']",0.6096755100231704,0,0,32
9,Ectoderm Differentiation WP2858,0.012464725468387524,1.628427817013425,7.140415925271769,"['CTNND2', 'ARHGDIG', 'PRKAG2', 'LDB2', 'CELSR2', 'WDR44', 'PHF8', 'CDH6', 'SOCS2', 'MECP2', 'TRPM2', 'MYC', 'HESX1', 'PLXNA2', 'DMD', 'FYN', 'CTNNA2', 'CDON', 'RAB8B', 'BCAS3', 'SMAD4', 'KCNK10', 'JUP', 'C1GALT1', 'PTPN13', 'SERPINB6', 'PAN2', 'CLDN11', 'GLB1', 'ZNF219', 'BCOR', 'TRIM33', 'ASTN1', 'BMPR1A']",0.6096755100231704,0,0,34
10,Insulin signaling in adipocytes (diabetic condition) WP3635,0.012508776988648763,8.879090595935239,38.90217913667423,"['RPS6KB1', 'INSR', 'AKT2', 'RPS6']",0.6096755100231704,0,0,4
11,Insulin signaling in adipocytes (normal condition) WP3634,0.012508776988648763,8.879090595935239,38.90217913667423,"['RPS6KB1', 'INSR', 'AKT2', 'RPS6']",0.6096755100231704,0,0,4
12,MAPK and NFkB signaling pathways inhibited by Yersinia YopJ WP3849,0.012925982544660857,4.441227163047225,19.312746678863874,"['IKBKB', 'MAP3K1', 'CHUK', 'RAF1', 'MAP3K14', 'MAP2K6']",0.6096755100231704,0,0,6
13,Ebstein-Barr virus LMP1 signaling WP262,0.01428675370615203,3.230957383423751,13.72647199667223,"['IKBKB', 'MAP3K3', 'MAPK8', 'CHUK', 'TRADD', 'MAP3K7', 'MAP3K14', 'PDLIM7']",0.622023276744773,0,0,8
14,Cardiac Hypertrophic Response WP2795,0.017748587952156,2.032712358551169,8.194776852011062,"['HDAC4', 'MAP3K1', 'CHUK', 'IGF1', 'HDAC7', 'IKBKB', 'PPP3CA', 'MAPK8', 'AKT2', 'PRKD1', 'RAF1', 'MAP2K7', 'MAP3K7', 'IKBKE', 'MAP3K14', 'MAP2K6']",0.6436129302771851,0,0,16
15,Angiopoietin Like Protein 8 Regulatory Pathway WP3915,0.01788554087195549,1.6009066927210551,6.441668580441112,"['SHC2', 'GSK3A', 'PRKAA1', 'PIK3R4', 'PRKAG2', 'IRS2', 'CBLB', 'PIK3CB', 'CBL', 'RPTOR', 'RPS6KA3', 'GYS1', 'RPS6KA6', 'MAPK8', 'RXRA', 'AKT2', 'MAP3K8', 'MAP2K7', 'MAPK6', 'MAP3K7', 'EIF4E', 'MAP2K6', 'MAP4K4', 'MAP3K2', 'MAP3K3', 'MAP3K1', 'INSR', 'MLXIPL', 'RPS6KB1', 'MAP3K10', 'RAF1', 'MAP3K14']",0.6436129302771851,0,0,32
16,Structural Pathway of Interleukin 1 (IL-1) WP2637,0.018194005096174845,2.0840897302904566,8.350245480883435,"['MAP3K3', 'MAP3K1', 'CHUK', 'IKBKB', 'MAPK8', 'MYC', 'MKNK1', 'TOLLIP', 'MAPKAPK2', 'MAP3K8', 'MAP2K7', 'MAP3K7', 'EIF4E', 'MAP3K14', 'MAP2K6']",0.6436129302771851,0,0,15
17,Cell-type Dependent Selectivity of CCK2R Signaling WP3679,0.02032012193479968,3.8064706751366524,14.83055657101468,"['CNR1', 'TRPC1', 'GNAQ', 'ITPR1', 'RYR3', 'GNAI1']",0.6701701529608965,0,0,6
18,Gastric Cancer Network 1 WP2361,0.021856120396028546,2.6656314699792962,10.191440257805494,"['NUP107', 'INO80D', 'RNF216', 'CASTOR3', 'H3F3A', 'ACTL6A', 'CEP192', 'GATD3B', 'AURKA']",0.6701701529608965,0,0,9
19,DDX1 as a regulatory component of the Drosha microprocessor WP2942,0.024957464837190146,5.91893443564129,21.8443147202283,"['RAD50', 'MRE11', 'DROSHA', 'ATM']",0.6701701529608965,0,0,4
20,Regulation of Actin Cytoskeleton WP51,0.025544865225928217,1.5129168131541229,5.548348501922405,"['CHRM2', 'NCKAP1', 'CHRM3', 'CHRM1', 'ROCK1', 'PIK3R4', 'PIK3CB', 'FGD1', 'PIK3C2B', 'CFL2', 'FGF20', 'RAC3', 'CSK', 'PIP4K2C', 'CD14', 'WASF1', 'PAK3', 'MAPK6', 'WASF2', 'PAK5', 'GSN', 'ACTN1', 'F2R', 'RDX', 'RRAS2', 'SSH2', 'SSH3', 'PTK2', 'SSH1', 'FGF17', 'FGF18', 'ARHGEF4', 'KRAS', 'RAF1', 'ARHGEF7']",0.6701701529608965,0,0,35
21,TNF-alpha signaling pathway WP231,0.025916809653366603,1.6683142559833506,6.094124251267674,"['MAP3K3', 'MAP3K1', 'APAF1', 'KSR1', 'CHUK', 'TRADD', 'CUL1', 'OTUD7B', 'KSR2', 'TNFRSF1B', 'IKBKB', 'MAPK8', 'RFK', 'MADD', 'MAP3K8', 'KRAS', 'BTRC', 'RAF1', 'RFFL', 'MAP2K7', 'NFKBIE', 'MAP3K7', 'MAP3K14', 'MAP2K6']",0.6701701529608965,0,0,24
22,miRNA regulation of DNA damage response WP1530,0.02604901654618326,1.7977323628219486,6.557723644468162,"['RB1', 'CDKN1B', 'MRE11', 'APAF1', 'SMC1A', 'CCNB3', 'RAD52', 'CCND3', 'RAD50', 'CDK6', 'CCND1', 'CCNE2', 'CCNE1', 'MYC', 'CCNG1', 'TLK2', 'ABL1', 'ATM', 'RAD9A']",0.6701701529608965,0,0,19
23,Sleep regulation WP3591,0.029320007345315258,2.338353650782116,8.253184489254194,"['CHRNB2', 'GRIN2A', 'AHCY', 'ADORA2A', 'NPY2R', 'IL18', 'BTBD9', 'NPAS2', 'ADA', 'HCRTR1']",0.7113438308635751,0,0,10
24,Insulin Signaling WP481,0.031062987933985556,1.4585521808632107,5.063711420882917,"['SHC2', 'GSK3A', 'PRKAA1', 'INPPL1', 'PIK3R4', 'IRS2', 'CBLB', 'PIK3CB', 'CBL', 'IKBKB', 'RPS6KA3', 'GYS1', 'RPS6KA6', 'MAPK8', 'KIF5B', 'AKT2', 'MAP3K8', 'STX4', 'MAP2K7', 'MAPK6', 'MAP3K7', 'EIF4E', 'MAP2K6', 'MAP4K4', 'MAP3K2', 'MAP3K3', 'RAB4A', 'MAP3K1', 'INSR', 'SORBS1', 'INPP4A', 'RPS6KB1', 'RHOJ', 'MAP3K10', 'RAF1', 'SGK1', 'MAP3K14', 'ARF6']",0.7113438308635751,0,0,38
25,Transcription factor regulation in adipogenesis WP3599,0.03407118550658159,2.826112852664577,9.550292352717982,"['CEBPA', 'MAPK8', 'RXRA', 'INSR', 'IRS2', 'LPIN1', 'PPARGC1A']",0.7113438308635751,0,0,7
26,Parkinson's disease pathway WP2371,0.03638664116636905,2.1249249339418688,7.041052606422363,"['PRKN', 'ATXN2', 'UCHL1', 'APAF1', 'CCNE2', 'CCNE1', 'LRRK2', 'HTRA2', 'UBE2L6', 'UBE2G1', 'EPRS']",0.7113438308635751,0,0,11
27,7-oxo-C and 7beta-HC pathways WP5064,0.03694198601791189,2.3516624040920715,7.756738658968004,"['CYP27A1', 'ACOT9', 'EBP', 'DBP', 'AMACR', 'SCP2', 'ACOT11', 'ACOT2', 'ACOT6']",0.7113438308635751,0,0,9
28,Signal transduction through IL1R WP4496,0.03694198601791189,2.3516624040920715,7.756738658968004,"['IKBKB', 'MAPK8', 'TGFB2', 'MAP3K1', 'CHUK', 'TOLLIP', 'MAP3K7', 'MAP3K14', 'MAP2K6']",0.7113438308635751,0,0,9
29,DNA damage response WP707,0.037107635813097783,1.739672219964784,5.7303628881426185,"['RB1', 'CDKN1B', 'MRE11', 'APAF1', 'SMC1A', 'CCNB3', 'RAD52', 'CCND3', 'RAD50', 'CDK6', 'CCND1', 'CCNE2', 'CCNE1', 'MYC', 'TLK2', 'ABL1', 'ATM', 'RAD9A']",0.7113438308635751,0,0,18
30,Small cell lung cancer WP4658,0.03770373661821069,1.5932408716045163,5.222637323487144,"['ITGB1', 'RB1', 'CDKN1B', 'APAF1', 'CHUK', 'ITGA3', 'LAMA4', 'ITGA2B', 'LAMA3', 'PIK3CB', 'FHIT', 'PTK2', 'IKBKB', 'RXRA', 'CDK6', 'CCND1', 'CCNE2', 'TRAF3', 'CCNE1', 'MYC', 'AKT2', 'RARB', 'COL4A5', 'POLK']",0.7113438308635751,0,0,24
31,TCA Cycle and Deficiency of Pyruvate Dehydrogenase complex (PDHc) WP2453,0.042578724469789726,2.9601286912558886,9.343351906271403,"['ACLY', 'IDH1', 'OGDH', 'DLST', 'ACO1', 'IDH3A']",0.7734792317158676,0,0,6
32,Oxysterols derived from cholesterol WP4545,0.04452216394758469,2.0362281307550645,6.336269838461269,"['CYP27A1', 'ACOT9', 'EBP', 'DBP', 'AMACR', 'SCP2', 'NR1H2', 'ACOT11', 'ACOT2', 'CYP7B1', 'ACOT6']",0.7734792317158676,0,0,11
33,Glucocorticoid Receptor Pathway WP2880,0.04548271485552125,1.717379679144385,5.307429520173743,"['SRGN', 'SLC26A2', 'ABHD2', 'AMIGO2', 'CUL1', 'EPB41L4B', 'AKAP13', 'RXRA', 'NAV3', 'ADGRF4', 'DNER', 'ENC1', 'ALOX5AP', 'BHLHE40', 'STOM', 'SNAI2', 'MFGE8']",0.7734792317158676,0,0,17
34,Rett syndrome causing genes WP4312,0.04646341674618286,1.8298123258982126,5.615858734474193,"['KDM5B', 'SRRM3', 'CDKL5', 'HDAC1', 'SMC1A', 'SMARCA2', 'GRIN2B', 'MECP2', 'XAB2', 'GRIN2A', 'NCOR1', 'TAF1B', 'HAP1', 'SCN2A']",0.7734792317158676,0,0,14
35,Endoderm differentiation WP2853,0.05137518332216699,1.465893297112894,4.351650897304274,"['TRIM71', 'CTBP2', 'CDC73', 'MBTD1', 'EPB41L5', 'CAND1', 'UBR5', 'CEP250', 'DIP2A', 'BPTF', 'SMAD2', 'SMAD4', 'ATP8B2', 'SFMBT1', 'TET1', 'ELP4', 'TRERF1', 'EMSY', 'PBX1', 'PARP8', 'TNRC6C', 'DDAH1', 'AEBP2', 'PLCH1', 'WDFY2', 'NAA15', 'TOX', 'AHDC1', 'BMPR1A']",0.830810107438472,0,0,29
36,"GPCRs, Class C Metabotropic glutamate, pheromone WP501",0.053145396789605726,3.1709658363690068,9.305908864123953,"['GRM4', 'GRM7', 'GRM8', 'GPRC5C', 'GRM1']",0.8355637384143566,0,0,5
37,Sphingolipid Metabolism (integrated pathway) WP4726,0.059158765475056684,2.2204208347706107,6.278307652952969,"['UGT8', 'CERS4', 'CERS5', 'CERS6', 'SGMS1', 'DEGS1', 'PLPP3', 'SGPP2']",0.8627806732185503,0,0,8
38,Vitamin D in inflammatory diseases WP4482,0.05937938669738427,2.3909549071618037,6.75159792476284,"['IKBKB', 'PPP3CA', 'SMAD4', 'MAP3K1', 'RXRA', 'CHUK', 'MAP2K6']",0.8627806732185503,0,0,7
39,Pathways affected in adenoid cystic carcinoma WP3651,0.05980368320055162,1.6424552429667518,4.62628401929139,"['MAGI1', 'CEBPA', 'SETD2', 'KMT2C', 'MGA', 'JMJD1C', 'SMC1A', 'SMARCA2', 'FOXP2', 'NCOR1', 'KANSL1', 'MYC', 'NSD1', 'ATM', 'BCOR', 'RAF1', 'KDM6A']",0.8627806732185503,0,0,17
40,Metabolic reprogramming in colon cancer WP4290,0.06097389916738872,1.8382705020546721,5.142211334695908,"['RPIA', 'ACLY', 'TIGAR', 'PKM', 'GOT2', 'DLST', 'ENO1', 'ALDOB', 'TKT', 'PAICS', 'GAPDH', 'IDH3A']",0.8627806732185503,0,0,12
41,NLR Proteins WP288,0.06595499421970698,3.5508095074061314,9.65387937210163,"['IKBKB', 'MAPK8', 'CHUK', 'MAP3K7']",0.9105006519110768,0,0,4
42,Canonical and non-canonical TGF-B signaling WP3874,0.07591987372179301,2.421547428786312,6.24293521716614,"['SMAD2', 'SMAD4', 'MAPK8', 'BMPR2', 'BMP1', 'BMPR1A']",0.9658227185883772,0,0,6
43,Mitochondrial Gene Expression WP391,0.07591987372179301,2.421547428786312,6.24293521716614,"['PPP3CA', 'MYEF2', 'SP1', 'NRF1', 'PPARGC1A', 'HCFC1']",0.9658227185883772,0,0,6
44,Proteoglycan biosynthesis WP4784,0.07591987372179301,2.421547428786312,6.24293521716614,"['CSGALNACT1', 'EXT2', 'SLC26A2', 'CHSY1', 'B3GAT3', 'PAPSS2']",0.9658227185883772,0,0,6
45,Circadian rhythm related genes WP3594,0.07821646796795205,1.324435465840493,3.3750258738306194,"['KDM5A', 'PRKAA1', 'PHLPP1', 'AHCY', 'CHRM1', 'KMT2A', 'DHX9', 'HDAC1', 'NPY2R', 'CUL1', 'OPRL1', 'RBM4B', 'CCAR2', 'ARNTL2', 'NPAS2', 'ARNTL', 'MAPK8', 'DBP', 'BTRC', 'PPARGC1A', 'CHRNB2', 'ARNT', 'BTBD9', 'SIRT1', 'HCRTR1', 'SETX', 'F7', 'NCOR1', 'ADORA2A', 'GNAQ', 'KCNMA1', 'BHLHE40', 'KLF9', 'CRY1', 'ID3', 'TOP1', 'PPARA', 'ADA', 'LGR4']",0.9658227185883772,0,0,39
46,exRNA mechanism of action and biogenesis WP2805,0.0802008264552186,4.43767217630854,11.197229664311132,"['AGO2', 'DROSHA', 'DICER1']",0.9658227185883772,0,0,3
47,FTO Obesity Variant Mechanism WP3407,0.0802008264552186,4.43767217630854,11.197229664311132,"['FTO', 'PRDM16', 'PPARGC1A']",0.9658227185883772,0,0,3
48,G1 to S cell cycle control WP45,0.08259714526119809,1.5797686306160883,3.93959566850749,"['RB1', 'CDKN1B', 'MYT1', 'ORC5', 'CREB3', 'CCND3', 'CDK6', 'CCND1', 'CCNE2', 'CCNE1', 'MYC', 'ORC2', 'MCM3', 'ATM', 'MNAT1', 'MCM2']",0.9712318463682372,0,0,16
49,Integrin-mediated Cell Adhesion WP185,0.08573075121929617,1.4398868941806178,3.5371450695568343,"['ITGB1', 'GIT2', 'CAV3', 'ITGB5', 'ROCK1', 'ITGA3', 'ITGA2B', 'ILK', 'SORBS1', 'PTK2', 'AKT2', 'CAPN2', 'CAPN3', 'RAC3', 'FYN', 'CSK', 'CAPN1', 'RAF1', 'ARHGEF7', 'PAK3', 'MAPK6', 'MAP2K6', 'ITGA9']",0.9712318463682372,0,0,23
50,Glycogen Synthesis and Degradation WP500,0.0890996875584565,1.7447957774269929,4.218915232188385,"['GYS1', 'GSK3A', 'PHKG1', 'PPP2R1B', 'PPP2R2B', 'GBE1', 'AGL', 'PPP2R2A', 'PHKB', 'PPP2R5C', 'PHKA2']",0.9712318463682372,0,0,11
51,16p11.2 distal deletion syndrome WP4950,0.08972864906031994,1.9734007895442873,4.75780057673796,"['C3', 'RAB4A', 'PLN', 'RABEP2', 'PRMT1', 'INSR', 'TUFM', 'SDCCAG8']",0.9712318463682372,0,0,8
52,Integrated breast cancer pathway WP1984,0.0924871112019226,1.3340292275574113,3.1759046823310415,"['RB1', 'GSK3A', 'USP15', 'MRE11', 'BMPR2', 'USP38', 'HDAC1', 'TRADD', 'MYCBP2', 'AURKA', 'CCND1', 'RASGEF1A', 'ZMIZ1', 'MYC', 'ABL1', 'RPP38', 'SMAD2', 'SMAD4', 'CHUK', 'PPP4R3A', 'PPP4R3B', 'MYT1', 'SIRT1', 'CDC25B', 'HIPK2', 'ITPKC', 'RAD50', 'SP1', 'NF1', 'ATM', 'KRAS', 'ZNF655', 'BMPR1A']",0.9712318463682372,0,0,33
53,PKC-gamma calcium signaling pathway in ataxia WP4760,0.09377404643335495,2.07183908045977,4.903767863214428,"['GRIA1', 'GNAQ', 'ITPR1', 'CACNA1A', 'RYR3', 'GRM1', 'GRIA3']",0.9712318463682372,0,0,7
54,Urea cycle and associated pathways WP4595,0.09377404643335495,2.07183908045977,4.903767863214428,"['SLC25A15', 'LDHB', 'OAT', 'CPS1', 'GOT2', 'NOS1', 'SLC25A12']",0.9712318463682372,0,0,7
55,Valproic acid pathway WP3871,0.09437765291564143,2.958778275347342,6.9840510247421435,"['HADHB', 'HDAC1', 'ACSM1', 'HSD17B10']",0.9712318463682372,0,0,4
56,Envelope proteins and their potential roles in EDMD physiopathology WP4535,0.09633637395219359,1.6655440414507772,3.897222019662301,"['SMAD2', 'TGFB2', 'SMAD4', 'SUN1', 'KIF5B', 'KRAS', 'LEMD3', 'LBR', 'YY1AP1', 'SYNE1', 'ADCY5', 'PLEC']",0.9736854938739568,0,0,12
57,"GPCRs, Other WP117",0.1002173568642598,1.5496236611019976,3.5647757836325975,"['CHRM2', 'CHRM3', 'ADGRV1', 'P2RY11', 'HTR1F', 'F2R', 'GPR55', 'CELSR2', 'GRM1', 'ADORA2A', 'CNR1', 'GRM8', 'ADGRL2', 'GPR135', 'ADGRL3']",0.980930820319668,0,0,15
58,Leptin signaling pathway WP2034,0.10051941268293418,1.4810199607707395,3.40250178785754,"['GSK3A', 'PRKAA1', 'CISH', 'CHUK', 'ROCK1', 'RPS6', 'PTK2', 'IKBKB', 'SOCS2', 'MAPK8', 'CCND1', 'RPS6KB1', 'SP1', 'CFL2', 'FYN', 'RAF1', 'EIF4E', 'SOCS7']",0.980930820319668,0,0,18
59,Retinoblastoma gene in cancer WP2446,0.10634284722602852,1.4333441344402607,3.2122489012361783,"['RB1', 'DNMT1', 'CDKN1B', 'HDAC1', 'FAF1', 'SMC3', 'SMC1A', 'SMARCA2', 'CDC25B', 'POLA1', 'CCND3', 'CDK6', 'CCND1', 'CCNE2', 'CCNE1', 'MYC', 'MCM3', 'ABL1', 'ZNF655', 'RAF1']",0.9951480220574164,0,0,20
60,Sphingolipid Metabolism (general overview) WP4725,0.11435821288049812,1.942198275862069,4.2115006895799345,"['CERS4', 'UGT8', 'CERS6', 'SGMS1', 'DEGS1', 'PLPP3', 'SGPP2']",0.9951480220574164,0,0,7
61,Genes related to primary cilium development (based on CRISPR) WP4536,0.11459279009585434,1.367379065610075,2.962249520093928,"['DYNC2H1', 'BBS2', 'OFD1', 'IFT172', 'CEP295', 'CEP120', 'WDR19', 'ARMC9', 'SCLT1', 'IFT80', 'CPLANE1', 'TTBK2', 'MIB1', 'ICK', 'WDR60', 'KIAA0753', 'CDK20', 'CEP162', 'WDPCP', 'CEP192', 'KIFAP3', 'IFT46', 'PIBF1', 'CEP44']",0.9951480220574164,0,0,24
62,RANKL/RANK signaling pathway WP2018,0.11636572899224355,1.5604419208427502,3.356537429281144,"['CHUK', 'MITF', 'GAB2', 'CBL', 'PAPSS2', 'PTK2', 'IKBKB', 'MAPK8', 'TRAF3', 'AKT2', 'MAP2K7', 'MAP3K7', 'MAP2K6']",0.9951480220574164,0,0,13
63,CAMKK2  Pathway WP4874,0.11914031042960632,1.737375101269241,3.6961845683523706,"['HDAC4', 'RPTOR', 'CHRM3', 'STIM1', 'NOS1', 'SMC1A', 'ARHGEF7', 'RAF1', 'SIRT1']",0.9951480220574164,0,0,9
64,Caloric restriction and aging WP4191,0.12163337689522452,3.3279958677685952,7.011234880717302,"['IGF1', 'PPARGC1A', 'SIRT1']",0.9951480220574164,0,0,3
65,Cholesterol Biosynthesis with Skeletal Dysplasias WP4804,0.12163337689522452,3.3279958677685952,7.011234880717302,"['EBP', 'DHCR24', 'LBR']",0.9951480220574164,0,0,3
66,Pentose Phosphate Metabolism WP134,0.12163337689522452,3.3279958677685952,7.011234880717302,"['RPIA', 'RPE', 'TKT']",0.9951480220574164,0,0,3
67,Ciliopathies WP4803,0.12478200329193856,1.2608480774933282,2.6240606755605396,"['INVS', 'IFT172', 'CEP120', 'DNAH6', 'PIK3R4', 'PKD2', 'CCDC28B', 'TTBK2', 'PKHD1', 'FLCN', 'TBC1D32', 'SUFU', 'KIAA0753', 'HYDIN', 'NPHP4', 'PIBF1', 'CEP290', 'TAPT1', 'DYNC2H1', 'BBS2', 'IQCB1', 'OFD1', 'CFAP52', 'WDR19', 'SCLT1', 'DNAAF5', 'IFT80', 'CPLANE1', 'TOPORS', 'ICK', 'WDR60', 'NME7', 'KIAA0586', 'ALMS1', 'WDPCP', 'CCDC151', 'KIZ', 'SDCCAG8']",0.9951480220574164,0,0,38
68,Cell cycle WP179,0.12708099815172189,1.3280749420499747,2.7397264570980897,"['RB1', 'CDKN1B', 'HDAC1', 'CUL1', 'SMC3', 'CDC14A', 'CCNB3', 'ORC5', 'CCND3', 'CCND1', 'MYC', 'ORC2', 'ABL1', 'SMAD2', 'TGFB2', 'SMAD4', 'SMC1A', 'CDC25B', 'CDK6', 'RBL1', 'CCNE2', 'CCNE1', 'MCM3', 'ATM', 'MAD1L1', 'MCM2']",0.9951480220574164,0,0,26
69,Farnesoid X receptor pathway WP2879,0.12751501741474414,2.535898823876778,5.222737230778264,"['RXRA', 'SLC10A1', 'IRS2', 'PPARGC1A']",0.9951480220574164,0,0,4
70,Glycerophospholipid Biosynthetic Pathway WP2533,0.12785675533389526,1.7757847533632287,3.6525135305264884,"['GPAM', 'IPMK', 'AGPS', 'CHPT1', 'PIK3CB', 'CEPT1', 'LPIN1', 'PI4K2A']",0.9951480220574164,0,0,8
71,Development of ureteric collection system WP5053,0.12826599708113304,1.6444853552205985,3.3771958189528792,"['ROBO2', 'ITGB1', 'TGFB2', 'CCND1', 'ILK', 'RARB', 'GFRA1', 'SLIT2', 'FAT4', 'ROBO1']",0.9951480220574164,0,0,10
72,Hedgehog Signaling Pathway WP4249,0.12826599708113304,1.6444853552205985,3.3771958189528792,"['CSNK1G3', 'GRK3', 'CCND1', 'SUFU', 'SPOP', 'FBXL17', 'SPOPL', 'ARRB1', 'CDON', 'CSNK1G1']",0.9951480220574164,0,0,10
73,Wnt/beta-catenin signaling pathway in leukemia WP3658,0.13708740452161097,1.8278093306288032,3.632106759079467,"['PYGO1', 'CCND1', 'JUP', 'MYC', 'FZD6', 'LRP6', 'RUNX1T1']",0.9951480220574164,0,0,7
74,Type 2 papillary renal cell carcinoma WP4241,0.13845530941206394,1.664855072463768,3.291764237278446,"['EGLN1', 'SETD2', 'TGFB2', 'EPAS1', 'CADM2', 'DVL2', 'TFEB', 'ARNT', 'COL21A1']",0.9951480220574164,0,0,9
75,Pancreatic adenocarcinoma pathway WP4263,0.14014796609206925,1.36687005408862,2.6859769033616905,"['RB1', 'SMAD2', 'TGFB2', 'SMAD4', 'RALB', 'CHUK', 'PIK3CB', 'IKBKB', 'TIAM1', 'MAPK8', 'CDK6', 'CCND1', 'RPS6KB1', 'AKT2', 'RAC3', 'KRAS', 'POLK', 'RAF1', 'PAK3', 'PAK5']",0.9951480220574164,0,0,20
76,Synaptic signaling pathways associated with autism spectrum disorder WP4539,0.14189581405284224,1.5224278312361215,2.972787269949746,"['RPTOR', 'PRKAA1', 'GRIN2A', 'GRIN3A', 'RPS6KB1', 'AKT2', 'NF1', 'PRKAG2', 'KRAS', 'PIK3CB', 'GRIN2B', 'GRM1']",0.9951480220574164,0,0,12
77,MicroRNAs in cardiomyocyte hypertrophy WP1544,0.14873921484287342,1.3784509614351703,2.6267220374937046,"['HDAC4', 'MYEF2', 'CISH', 'CHUK', 'ROCK1', 'PIK3CB', 'IGF1', 'HDAC7', 'LRP6', 'IKBKB', 'PPP3CA', 'MAPK8', 'AKT2', 'RAF1', 'MAP2K7', 'IKBKE', 'MAP3K14', 'MAP2K6']",0.9951480220574164,0,0,18
78,Regulation of Microtubule Cytoskeleton WP2038,0.1537184891306065,1.5262215124309393,2.8580517653020903,"['TIAM1', 'PARD6A', 'ROCK1', 'CFL2', 'TAOK1', 'GNAQ', 'MAPKAPK2', 'ABL1', 'CLASP1', 'MARK2', 'MARK1']",0.9951480220574164,0,0,11
79,"4-hydroxytamoxifen, Dexamethasone, and Retinoic Acids Regulation of p27 Expression WP3879",0.15623446258565632,2.017260823256688,3.7448378175393047,"['PRKAA1', 'MKNK1', 'RAF1', 'EIF4E', 'MAP2K6']",0.9951480220574164,0,0,5
80,Sulindac Metabolic Pathway WP2542,0.1567501346654463,4.436488812392427,8.221267357575465,"['MSRA', 'MSRB3']",0.9951480220574164,0,0,2
81,Arrhythmogenic Right Ventricular Cardiomyopathy WP2118,0.1578756829633034,1.3932623897016434,2.5718890472580305,"['ITGB1', 'ITGB5', 'JUP', 'ITGA3', 'CACNA2D1', 'ACTN1', 'ITGA2B', 'ATP2A2', 'CACNA2D2', 'CACNA1D', 'CACNG7', 'CACNB4', 'DMD', 'CTNNA2', 'CACNG2', 'ITGA9']",0.9951480220574164,0,0,16
82,Alzheimer's disease WP2059,0.16250980090535516,1.3549817836210993,2.4620248891452996,"['APAF1', 'ITPR1', 'ATP2A2', 'CACNA1D', 'IDE', 'HSD17B10', 'AGER', 'GRIN2B', 'RYR3', 'PPP3CA', 'GRIN2A', 'PPP3CC', 'GNAQ', 'CAPN2', 'NOS1', 'CAPN1', 'ATF6', 'GAPDH']",0.9951480220574164,0,0,18
83,IL-1 signaling pathway WP195,0.16380626259974068,1.4430718728403593,2.6106192958089762,"['MAP3K2', 'MAP3K3', 'MAP3K1', 'CHUK', 'IKBKB', 'MAPK8', 'TOLLIP', 'MAPKAPK2', 'PELI1', 'MAP2K7', 'MAP3K7', 'MAP3K14', 'MAP2K6']",0.9951480220574164,0,0,13
84,7q11.23 copy number variation syndrome WP4932,0.16793050366045417,1.3029693818601964,2.3247645561282657,"['RB1', 'ATPAF2', 'TSG101', 'UBE2E1', 'HMGA1', 'DLST', 'UBE2L6', 'VPS37A', 'ATP5F1D', 'USF1', 'MLXIPL', 'MYC', 'BCL7B', 'OGDH', 'MVB12A', 'GTF2IRD1', 'ERCC6', 'GAPDH', 'CLASP1', 'GTF2I', 'CLASP2', 'BRD4']",0.9951480220574164,0,0,22
85,Canonical NF-KB pathway WP4562,0.1689709372181208,2.6621900826446283,4.7334499670674095,"['IKBKB', 'CHUK', 'NFKBIE']",0.9951480220574164,0,0,3
86,Heme Biosynthesis WP561,0.1689709372181208,2.6621900826446283,4.7334499670674095,"['UROD', 'HMBS', 'CPOX']",0.9951480220574164,0,0,3
87,Prion disease pathway WP3995,0.17300773512052078,1.6140989055787263,2.831805745544532,"['RXRA', 'BCL11A', 'NCAM1', 'FYN', 'CTCF', 'SMC3', 'CHD2', 'PTK2']",0.9951480220574164,0,0,8
88,Effect of progerin on genes involved in Hutchinson-Gilford progeria syndrome WP4320,0.17517932948415418,1.7752499138228197,3.0923878706166796,"['RB1', 'MBD3', 'HDAC1', 'H3F3A', 'MBD2', 'CHD3']",0.9951480220574164,0,0,6
89,NAD Metabolism in Oncogene-Induced Senescence and Mitochondrial Dysfunction-Associated Senescence WP5046,0.17517932948415418,1.7752499138228197,3.0923878706166796,"['RB1', 'PRKAA1', 'SCO2', 'GOT2', 'HMGA1', 'SIRT1']",0.9951480220574164,0,0,6
90,Purinergic signaling WP4900,0.17517932948415418,1.7752499138228197,3.0923878706166796,"['P2RX7', 'P2RY11', 'ADORA2A', 'P2RY14', 'GNAI3', 'GNAI1']",0.9951480220574164,0,0,6
91,Joubert Syndrome WP4656,0.1752335238476231,1.348109243697479,2.3479152842258593,"['INVS', 'OFD1', 'BBS2', 'MRE11', 'PDE6G', 'CEP120', 'ARMC9', 'MYO5A', 'CPLANE1', 'RAD50', 'KIAA0586', 'SUFU', 'NPHP4', 'ATM', 'PCNT', 'CEP290', 'PIBF1']",0.9951480220574164,0,0,17
92,Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling WP3850,0.1814727135964567,1.5365504061156234,2.622353712015526,"['ITGB1', 'RPTOR', 'SMAD2', 'RPS6KB1', 'JKAMP', 'ILK', 'IGF1', 'PPARGC1A', 'EIF4E']",0.9951480220574164,0,0,9
93,Host-pathogen interaction of human coronaviruses - MAPK signaling WP4877,0.1814727135964567,1.5365504061156234,2.622353712015526,"['RPS6KA3', 'MAPK8', 'MAP3K1', 'IFI27', 'MAP3K10', 'MAP2K7', 'RAF1', 'EIF4E', 'MAP2K6']",0.9951480220574164,0,0,9
94,PPAR-alpha pathway WP2878,0.18969888067470259,1.8490121755111417,3.073644931998007,"['RXRA', 'CCND1', 'SCP2', 'MYC', 'PPARA']",0.9951480220574164,0,0,5
95,Energy Metabolism WP1541,0.19304838401755797,1.4362203444913877,2.3623159431202105,"['PPP3CA', 'PRKAA1', 'RXRA', 'PPP3CC', 'HDAC1', 'PRMT1', 'PRKAG2', 'NRF1', 'PPARA', 'PPARGC1A', 'SIRT1']",0.9951480220574164,0,0,11
96,Translation inhibitors in chronically activated PDGFRA cells WP4566,0.19304838401755797,1.4362203444913877,2.3623159431202105,"['EIF4A2', 'RPTOR', 'MAPK8', 'RPS6KB1', 'AKT2', 'RPS6', 'PIK3CB', 'MAP2K7', 'EIF4E', 'MAP2K6', 'EIF4G1']",0.9951480220574164,0,0,11
97,Gastrin signaling pathway WP4659,0.19460316896733168,1.261138507902262,2.064222460869094,"['ITGB1', 'YES1', 'CDKN1B', 'CHUK', 'ROCK1', 'PRKCE', 'ARHGEF28', 'RPS6', 'ARRB1', 'PTK2', 'HDAC7', 'IKBKB', 'MAPK8', 'CCND1', 'RPS6KB1', 'SP1', 'MYC', 'GNAQ', 'KIT', 'FYN', 'KRAS', 'PRKD1', 'RAF1']",0.9951480220574164,0,0,23
98,Homologous recombination WP186,0.20516145853278372,1.972059555249359,3.123659523293253,"['RAD52', 'RAD50', 'MRE11', 'ATM']",0.9951480220574164,0,0,4
99,Constitutive Androstane Receptor Pathway WP2875,0.20570631395632016,1.6641675284384696,2.631557744621005,"['RXRA', 'NCOA6', 'SP1', 'SMC1A', 'CYP3A5', 'PPARGC1A']",0.9951480220574164,0,0,6
100,Head and Neck Squamous Cell Carcinoma WP4674,0.20583314327891122,1.3155514559872914,2.0794782712202498,"['RB1', 'NOTCH2', 'PRKAA1', 'SMAD4', 'MAML1', 'RPS6', 'PIK3CB', 'RPTOR', 'FKBP1A', 'CDK6', 'CCND1', 'TRAF3', 'AKT2', 'KRAS', 'CSMD3', 'EIF4E']",0.9951480220574164,0,0,16
101,Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms WP4534,0.21025595144975429,1.4318482969033595,2.2328667228446277,"['ITGB1', 'LATS1', 'ACTA2', 'MAPK8', 'ITGB5', 'SGMS1', 'PAK3', 'YY1AP1', 'PAK5', 'MAP4K4']",0.9951480220574164,0,0,10
102,Monoamine GPCRs WP58,0.2165607456504171,1.5532758620689655,2.376332184901012,"['CHRM2', 'CHRM3', 'CHRM1', 'HTR1F', 'ADRA1A', 'ADRA2A', 'DRD5']",0.9951480220574164,0,0,7
103,Biotin Metabolism (including IEMs) WP5031,0.2204789164276661,2.21831955922865,3.3539953690089956,"['PCCA', 'HLCS', 'MCCC1']",0.9951480220574164,0,0,3
104,Estrogen Receptor Pathway WP2881,0.2204789164276661,2.21831955922865,3.3539953690089956,"['GPAM', 'SP1', 'PPARA']",0.9951480220574164,0,0,3
105,Supression of HMGB1 mediated inflammation by THBD WP4479,0.2204789164276661,2.21831955922865,3.3539953690089956,"['IKBKB', 'CHUK', 'AGER']",0.9951480220574164,0,0,3
106,Thiamine metabolic pathways WP4297,0.2204789164276661,2.21831955922865,3.3539953690089956,"['TPK1', 'OGDH', 'TKT']",0.9951480220574164,0,0,3
107,Trans-sulfuration pathway WP2333,0.2204789164276661,2.21831955922865,3.3539953690089956,"['MPST', 'DNMT1', 'AHCY']",0.9951480220574164,0,0,3
108,ErbB signaling pathway WP673,0.22387896928503204,1.2591319717203457,1.884479473686324,"['SHC2', 'CDKN1B', 'CBLB', 'PIK3CB', 'NRG2', 'CBL', 'PTK2', 'MAPK8', 'CCND1', 'RPS6KB1', 'MYC', 'AKT2', 'ABL1', 'KRAS', 'RAF1', 'PAK3', 'MAP2K7', 'PAK5', 'HBEGF']",0.9951480220574164,0,0,19
109,TNF related weak inducer of apoptosis (TWEAK) Signaling Pathway WP2036,0.22962298083598282,1.4265749778172139,2.098943344429848,"['IKBKB', 'MAPK8', 'CHUK', 'HDAC1', 'TRAF3', 'AKT2', 'RAF1', 'MAP3K7', 'MAP3K14']",0.9951480220574164,0,0,9
110,let-7 inhibition of ES cell reprogramming WP3299,0.23034704985320562,2.957429718875502,4.342004251958724,"['TRIM71', 'MYC']",0.9951480220574164,0,0,2
111,miR-517 relationship with ARCN1 and USP1 WP3596,0.23034704985320562,2.957429718875502,4.342004251958724,"['USP1', 'ARCN1']",0.9951480220574164,0,0,2
112,Neurodegeneration with brain iron accumulation (NBIA) subtypes pathway WP4577,0.233544321373165,1.3869951674145669,2.0172227566942857,"['RPTOR', 'MECP2', 'PRKAA1', 'DCAF17', 'SCP2', 'PIK3R4', 'ATG10', 'ATG2A', 'ATG7', 'FTL']",0.9951480220574164,0,0,10
113,MAPK Signaling Pathway WP382,0.2344805655533813,1.1411001566739272,1.655031778588961,"['PTPRR', 'LRRK2', 'CACNA1A', 'CACNA1D', 'ARRB1', 'CACNA1E', 'IKBKB', 'RPS6KA3', 'PPP3CA', 'CACNG7', 'MAPK8', 'PPP3CC', 'MYC', 'AKT2', 'MKNK1', 'FGF20', 'RAC3', 'FLNB', 'MAP3K8', 'CD14', 'MAP2K7', 'CACNG2', 'MAP3K7', 'MAP4K4', 'MAP2K6', 'MAP3K2', 'TGFB2', 'MAP3K1', 'CHUK', 'CACNA2D1', 'NFATC3', 'CACNA2D2', 'RRAS2', 'CDC25B', 'FGF17', 'PPM1B', 'CACNB4', 'TAOK3', 'TAOK1', 'RASA1', 'MAPKAPK2', 'FGF18', 'RASA2', 'NF1', 'KRAS', 'RAF1', 'MAP3K14']",0.9951480220574164,0,0,47
114,TLR4 Signaling and Tolerance WP3851,0.23794682099365067,1.5661536589816898,2.2485394493787547,"['IKBKB', 'TRAM1', 'CHUK', 'TRAF3', 'IKBKE', 'MAP3K7']",0.9951480220574164,0,0,6
115,3q29 copy number variation syndrome WP4906,0.23967474602601616,1.3114751523528303,1.8734061891490361,"['DYNC2H1', 'GRIA1', 'MYCBP2', 'MAD2L1BP', 'RABL2B', 'ZNF76', 'FBXO45', 'SIRT1', 'PIGX', 'TF', 'WDR60', 'MYC', 'UBXN7']",0.9951480220574164,0,0,13
116,Cytoplasmic Ribosomal Proteins WP477,0.24012372621461575,1.2405185758513932,1.7697249944126017,"['RPL4', 'RPS9', 'RPLP1', 'RPS5', 'RPLP0', 'RPS6', 'MRPL19', 'RPL13A', 'RPL23A', 'RPS6KA3', 'RPS6KA6', 'RPS16', 'RPS19', 'RPS6KB1', 'RPS18', 'RPL27A', 'RPL36', 'RPL14', 'RPS12']",0.9951480220574164,0,0,19
117,Autophagy WP4923,0.2461287423253225,1.4791954022988505,2.07368482904734,"['RPTOR', 'PRKAA1', 'ATG9A', 'PIK3R4', 'PRKAG2', 'AMBRA1', 'ATG7']",0.9951480220574164,0,0,7
118,Regucalcin in proximal tubule epithelial kidney cells WP4838,0.2461287423253225,1.4791954022988505,2.07368482904734,"['SMAD2', 'ACTA2', 'SEC16B', 'SMAD4', 'APAF1', 'NOS1', 'RAF1']",0.9951480220574164,0,0,7
119,Type I collagen synthesis in the context of Osteogenesis imperfecta WP4786,0.2461287423253225,1.4791954022988505,2.07368482904734,"['BMP1', 'P4HA1', 'SERPINF1', 'ITPR1', 'P3H2', 'P3H1', 'LRP6']",0.9951480220574164,0,0,7
120,ID signaling pathway WP53,0.24808733617345616,1.7747158112297623,2.473908466379051,"['RB1', 'RBL1', 'CCNE1', 'ID3']",0.9951480220574164,0,0,4
121,EGF/EGFR signaling pathway WP437,0.25061234470855126,1.164863863150392,1.6119945006463205,"['SH3GL3', 'PTPRR', 'RALB', 'ROCK1', 'INPPL1', 'CBLB', 'AP2A1', 'FOXO4', 'CBL', 'PIK3C2B', 'AURKA', 'RPS6KA3', 'ATXN2', 'MAPK8', 'ABL1', 'REPS2', 'CSK', 'SH3GL2', 'MAP3K2', 'MAP3K3', 'MAP3K1', 'GAB2', 'PTPN12', 'PTK2', 'ITCH', 'RPS6KB1', 'SP1', 'RASA1', 'KRAS', 'RAF1', 'STAM2', 'ARF6']",0.9951480220574164,0,0,32
122,MAPK Cascade WP422,0.25160785629242294,1.4200758882373232,1.9595393285571256,"['MAP3K2', 'MAP3K3', 'MAP3K1', 'MAP2', 'KRAS', 'MAP2K7', 'RAF1', 'MAP2K6']",0.9951480220574164,0,0,8
123,Thymic Stromal LymphoPoietin (TSLP) Signaling Pathway WP2203,0.25529443877896607,1.3772756478903405,1.8804464177684663,"['HCK', 'MAPK8', 'YES1', 'CISH', 'MYC', 'RPS6', 'FYN', 'GAB2', 'PI4K2A']",0.9951480220574164,0,0,9
124,Imatinib and Chronic Myeloid Leukemia WP3640,0.2628844874543304,1.5846214433395687,2.1171185118100055,"['CDKN1B', 'MYC', 'KIT', 'ABL1', 'GAB2']",0.9951480220574164,0,0,5
125,Serotonin Receptor 2 and ELK-SRF/GATA4 signaling WP732,0.2628844874543304,1.5846214433395687,2.1171185118100055,"['GNAQ', 'MAPKAPK2', 'ITPR1', 'KRAS', 'RAF1']",0.9951480220574164,0,0,5
126,STING pathway in Kawasaki-like disease and COVID-19 WP4961,0.2628844874543304,1.5846214433395687,2.1171185118100055,"['IKBKB', 'CHUK', 'ITPR1', 'NFKBIE', 'IKBKE']",0.9951480220574164,0,0,5
127,MTHFR deficiency WP4288,0.27156662472597576,1.4790302194645524,1.9279865514056647,"['DNMT1', 'GRIN2A', 'SGMS1', 'EHMT1', 'CHPT1', 'COMT']",0.9951480220574164,0,0,6
128,Bone morphogenic protein (BMP) signaling and regulation WP1425,0.27452231390087956,1.9012691853600945,2.4578138957181266,"['SMAD4', 'BMPR2', 'BMPR1A']",0.9951480220574164,0,0,3
129,Nanoparticle triggered regulated necrosis WP2513,0.27452231390087956,1.9012691853600945,2.4578138957181266,"['MAPK8', 'TRADD', 'FTL']",0.9951480220574164,0,0,3
130,Neuroinflammation WP4919,0.27452231390087956,1.9012691853600945,2.4578138957181266,"['MAPK8', 'CHUK', 'ASCC1']",0.9951480220574164,0,0,3
131,Sphingolipid pathway WP1422,0.27684002399872115,1.4118495297805642,1.8132601928617935,"['UGT8', 'CERS4', 'CERS5', 'CERS6', 'SGMS1', 'SERINC1', 'SGPP2']",0.9951480220574164,0,0,7
132,p38 MAPK Signaling Pathway WP400,0.2800213324627723,1.3653514474487223,1.7379415094541963,"['TGFB2', 'MAP3K1', 'TRADD', 'MYC', 'MKNK1', 'MAPKAPK2', 'MAP3K7', 'MAP2K6']",0.9951480220574164,0,0,8
133,T-Cell antigen Receptor (TCR) pathway during Staphylococcus aureus infection WP3863,0.2829006821074094,1.28463943006688,1.6220620385626798,"['IKBKB', 'IL5', 'CHUK', 'MAP3K8', 'FYN', 'RAF1', 'CBL', 'MAP2K7', 'MAP3K7', 'MAP3K14', 'MALT1']",0.9951480220574164,0,0,11
134,Wnt Signaling Pathway WP363,0.2829006821074094,1.28463943006688,1.6220620385626798,"['GSK3A', 'MAPK8', 'CDK6', 'CCND1', 'RYK', 'MYC', 'DVL2', 'MAP3K7', 'PI4K2A', 'CSNK1G1', 'LRP6']",0.9951480220574164,0,0,11
135,Interactome of polycomb repressive complex 2 (PRC2)  WP2916,0.2926715267676092,1.6132527479410015,1.982210697898483,"['SETX', 'MORC3', 'AEBP2', 'EED']",0.9951480220574164,0,0,4
136,SREBF and miR33 in cholesterol and lipid homeostasis WP2011,0.2926715267676092,1.6132527479410015,1.982210697898483,"['PRKAA1', 'PPARA', 'SIRT1', 'PPARGC1A']",0.9951480220574164,0,0,4
137,Arachidonate Epoxygenase / Epoxide Hydrolase WP678,0.30542015520001975,2.2179001721170395,2.6305779645843805,"['COX8A', 'GSTP1']",0.9951480220574164,0,0,2
138,Metastatic brain tumor WP2249,0.30542015520001975,2.2179001721170395,2.6305779645843805,"['CDK6', 'MYC']",0.9951480220574164,0,0,2
139,mir-124 predicted interactions with cell cycle and differentiation  WP3595,0.30542015520001975,2.2179001721170395,2.6305779645843805,"['PRKAA1', 'STRADB']",0.9951480220574164,0,0,2
140,miRNA Biogenesis WP2338,0.30542015520001975,2.2179001721170395,2.6305779645843805,"['DROSHA', 'DICER1']",0.9951480220574164,0,0,2
141,Molybdenum cofactor (Moco) biosynthesis WP4507,0.30542015520001975,2.2179001721170395,2.6305779645843805,"['MARC2', 'GPHN']",0.9951480220574164,0,0,2
142,Pilocytic astrocytoma WP2253,0.30542015520001975,2.2179001721170395,2.6305779645843805,"['NF1', 'RAF1']",0.9951480220574164,0,0,2
143,Interferon type I signaling pathways WP585,0.3071265582860217,1.251602564102564,1.4775110374718383,"['RPTOR', 'MAP3K1', 'RPS6KB1', 'PRMT1', 'RPS6', 'IRS2', 'FYN', 'GAB2', 'CBL', 'EIF4E', 'MAP2K6']",0.9951480220574164,0,0,11
144,Genes controlling nephrogenesis WP4823,0.3084411513805047,1.350359820089955,1.5883259140981787,"['ROBO2', 'NOTCH2', 'ITGB1', 'EMX2', 'ITGA3', 'ILK', 'SLIT2']",0.9951480220574164,0,0,7
145,Senescence and Autophagy in Cancer WP615,0.3122214700339548,1.1748213304013193,1.3675419621795433,"['RB1', 'SH3GLB1', 'SMAD4', 'SPARC', 'CDKN1B', 'GSN', 'KMT2A', 'ATG10', 'HMGA1', 'IGF1', 'AMBRA1', 'CDC25B', 'RSL1D1', 'LAMP1', 'LAMP2', 'IGFBP7', 'RAF1', 'ATG7']",0.9951480220574164,0,0,18
146,Glioblastoma signaling pathways WP2261,0.31502483905868,1.1788602941176471,1.3617059925675543,"['RB1', 'CDKN1B', 'PIK3CB', 'FOXO4', 'CBL', 'PIK3C2B', 'CDK6', 'CCND1', 'CCNE1', 'AKT2', 'NF1', 'ATM', 'KRAS', 'MDM4', 'RAF1', 'MAP2K7', 'MAP2K6']",0.9951480220574164,0,0,17
147,AMP-activated protein kinase (AMPK) signaling WP1403,0.3263360960658522,1.2018112186132228,1.3458212033444934,"['PRKAA1', 'STRADB', 'INSR', 'PRKAG2', 'PIK3CB', 'CPT1C', 'ADIPOR1', 'EEF2', 'ADRA1A', 'RPTOR', 'GYS1', 'RPS6KB1', 'AKT2']",0.9951480220574164,0,0,13
148,Kit receptor signaling pathway WP304,0.32912113471624027,1.2101742816768724,1.3449022648323938,"['RPS6KA3', 'GRB7', 'MAPK8', 'RPS6KB1', 'RPS6', 'KIT', 'SNAI2', 'MITF', 'FYN', 'GAB2', 'RAF1', 'CBL']",0.9951480220574164,0,0,12
149,Biogenic Amine Synthesis WP550,0.32965004139353243,1.6634814049586777,1.8460046861188517,"['MAOA', 'GAD2', 'COMT']",0.9951480220574164,0,0,3
150,Computational Model of Aerobic Glycolysis WP4629,0.32965004139353243,1.6634814049586777,1.8460046861188517,"['PKM', 'ENO1', 'GAPDH']",0.9951480220574164,0,0,3
151,Osteopontin Signaling WP1434,0.32965004139353243,1.6634814049586777,1.8460046861188517,"['IKBKB', 'CHUK', 'MAP3K14']",0.9951480220574164,0,0,3
152,Pathogenesis of SARS-CoV-2 Mediated by nsp9-nsp10 Complex WP4884,0.32965004139353243,1.6634814049586777,1.8460046861188517,"['CD8B', 'NKRF', 'FYN']",0.9951480220574164,0,0,3
153,Sulfation Biotransformation Reaction WP692,0.32965004139353243,1.6634814049586777,1.8460046861188517,"['PAPSS2', 'PAPSS1', 'SULT1C4']",0.9951480220574164,0,0,3
154,Transcriptional cascade regulating adipogenesis WP4211,0.32965004139353243,1.6634814049586777,1.8460046861188517,"['CEBPA', 'KLF5', 'KLF15']",0.9951480220574164,0,0,3
155,Brain-derived neurotrophic factor (BDNF) signaling pathway WP2380,0.3296764371690968,1.1196705562804903,1.2424352657057445,"['GRIA1', 'GABRB3', 'SHC2', 'PRKAA1', 'DOCK3', 'IRS2', 'IKBKB', 'RPS6KA3', 'MAPK8', 'CNR1', 'NCAM1', 'FYN', 'EIF4E', 'GRIA3', 'NSF', 'MAP3K2', 'CDKL5', 'MAP3K1', 'KSR1', 'CHUK', 'KIDINS220', 'RPS6', 'RANBP9', 'EEF2', 'GRIN2B', 'TIAM1', 'RPS6KB1', 'RAF1']",0.9951480220574164,0,0,28
156,Phosphodiesterases in neuronal function WP4222,0.3318397378826741,1.220217541436464,1.3460258061174861,"['GRIA1', 'GRIN2A', 'ADORA2A', 'PDE1C', 'PDE6G', 'PDE2A', 'PPP1R1B', 'PDE5A', 'NOS1', 'GRIN2B', 'ADCY5']",0.9951480220574164,0,0,11
157,Proximal tubule transport WP4917,0.3344462270935896,1.2325010547309476,1.3499327302895094,"['ATP6V1A', 'ATP6V0B', 'SLC7A8', 'ATP6V0A4', 'ATP1A1', 'ATP1B1', 'SLC5A2', 'ATP6V0C', 'SLC26A6', 'ATP6V1B1']",0.9951480220574164,0,0,10
158,Pathways in clear cell renal cell carcinoma WP4018,0.33448083705133136,1.160633484162896,1.271097576149214,"['SETD2', 'TGFB2', 'KSR1', 'ARNT', 'ENO1', 'SDSL', 'RPTOR', 'ACLY', 'LDHB', 'PKM', 'LDHD', 'ME1', 'ALDOC', 'ENPP3', 'ALDOB', 'CEP290', 'GAPDH']",0.9951480220574164,0,0,17
159,Deregulation of Rab and Rab Effector Genes in Bladder Cancer WP2291,0.33815053994478766,1.4787001952003673,1.6033015336590106,"['MADD', 'MYRIP', 'SYTL5', 'SYTL3']",0.9951480220574164,0,0,4
160,MAPK pathway in congenital thyroid cancer WP4928,0.33815053994478766,1.4787001952003673,1.6033015336590106,"['KSR1', 'MYC', 'KRAS', 'RAF1']",0.9951480220574164,0,0,4
161,Transcription co-factors SKI and SKIL protein partners WP4533,0.33815053994478766,1.4787001952003673,1.6033015336590106,"['LATS1', 'MECP2', 'HDAC1', 'NF1']",0.9951480220574164,0,0,4
162,IL-2 signaling pathway WP49,0.3390072971578269,1.2676292317547924,1.3712371910150312,"['CISH', 'RPS6KB1', 'MYC', 'RPS6', 'FYN', 'GAB2', 'CBL', 'RAF1']",0.9951480220574164,0,0,8
163,Phosphoinositides metabolism WP4971,0.3390072971578269,1.2676292317547924,1.3712371910150312,"['PIKFYVE', 'PIP4P1', 'PIK3R4', 'PLCH1', 'PIK3CB', 'PIP4K2C', 'SBF2', 'PIK3C2B']",0.9951480220574164,0,0,8
164,Host-pathogen interaction of human coronaviruses - interferon induction WP4880,0.34067712906670233,1.2939942528735633,1.393399002419667,"['IKBKB', 'MAPK8', 'CHUK', 'DDX58', 'TRAF3', 'IKBKE', 'MAP3K7']",0.9951480220574164,0,0,7
165,Intracellular trafficking proteins involved in CMT neuropathy WP4856,0.34157561534469033,1.3309203722854188,1.4296563015560178,"['RAB4A', 'KIF1B', 'RABAC1', 'SBF2', 'GDAP1', 'DNM2']",0.9951480220574164,0,0,6
166,Focal Adhesion-PI3K-Akt-mTOR-signaling pathway WP3932,0.3436065960519582,1.0775781507521978,1.1511313639652585,"['CHRM2', 'ITGB1', 'CDKN1B', 'CHRM1', 'CSF3R', 'ITGB5', 'CAB39L', 'ITGA2B', 'IRS2', 'PIK3CB', 'PIK3C2B', 'RPTOR', 'IKBKB', 'GHR', 'GYS1', 'PPP2R1B', 'AKT2', 'NOS1', 'ITGA3', 'RPS6', 'F2R', 'PPP2R5C', 'CREB3', 'KIT', 'RAF1', 'ITGA9', 'PHLPP2', 'PFKFB4', 'PRKAA1', 'PHLPP1', 'EPAS1', 'LAMA4', 'COL11A2', 'LAMA3', 'PIK3R4', 'FGF20', 'PPARGC1A', 'EIF4E', 'INSR', 'VEGFD', 'IGF1', 'PTK2', 'EPOR', 'FGF17', 'RAB10', 'EFNA3', 'RPS6KB1', 'PPP2R2B', 'FGF18', 'KRAS']",0.9951480220574164,0,0,50
167,Calcium Regulation in the Cardiac Cell WP536,0.3485087495204195,1.109548611111111,1.1695662511935174,"['CHRM2', 'CHRM3', 'RGS17', 'CHRM1', 'ITPR1', 'GNAI3', 'CACNA1A', 'ATP2A2', 'CACNA1D', 'ARRB1', 'CACNA1E', 'ADRA1A', 'RYR3', 'GNAI1', 'ADCY5', 'PLN', 'RGS1', 'RGS9', 'RGS6', 'KCNJ3', 'PRKCE', 'ATP1B1', 'FKBP1A', 'GJB1', 'GNAQ', 'PRKD1', 'CASQ1']",0.9951480220574164,0,0,27
168,VEGFA-VEGFR2 Signaling Pathway WP3888,0.348645420495153,1.058603638591386,1.1154505061649609,"['ITGB1', 'ARF4', 'ITGB5', 'FAF1', 'AP2A1', 'LDB2', 'EPRS', 'PPP3CA', 'CCND1', 'CAPN2', 'LRRFIP2', 'IER5', 'CGNL1', 'ACOT9', 'CACNA2D1', 'PRKCE', 'TRPC1', 'RPS6', 'ARNT', 'RPL13A', 'SND1', 'EWSR1', 'KATNAL2', 'MAPKAPK2', 'RHOJ', 'TNFRSF25', 'PRKD1', 'ERG', 'TKT', 'ATP6V0D1', 'RAF1', 'ATF6', 'GAPDH', 'FJX1', 'ARF6', 'HBEGF', 'HDAC4', 'SHC2', 'PRKAA1', 'ROCK1', 'HDAC1', 'USP10', 'FLII', 'HTRA1', 'PBXIP1', 'FOXO4', 'CBL', 'FUT1', 'GIGYF2', 'APOLD1', 'HDAC7', 'MAPK8', 'MKNK1', 'FAM120A', 'ABL1', 'FLNB', 'IGFBP7', 'FYN', 'CSK', 'MAP2K7', 'WASF1', 'EIF4E', 'BRD4', 'MAP2K6', 'RBM39', 'RAB4A', 'PRRC2C', 'TRIP4', 'SMARCA2', 'QKI', 'PTK2', 'FMNL3', 'ITCH', 'RPS6KB1', 'SPIRE1', 'COPG1', 'EIF4G1']",0.9951480220574164,0,0,77
169,Hippo-Merlin Signaling Dysregulation WP4541,0.3561662110123708,1.1227738396413096,1.1591042997998102,"['ITGB1', 'ITGB5', 'ITGA3', 'INSR', 'ITGA2B', 'YY1AP1', 'PTK2', 'CDH6', 'LATS1', 'CUL4A', 'CCND1', 'CDH20', 'MYC', 'CDH10', 'KIT', 'CDH12', 'KRAS', 'PAK3', 'VGLL4', 'PAK5', 'ITGA9']",0.9951480220574164,0,0,21
170,Genotoxicity pathway WP4286,0.35692668662773014,1.1903634954857836,1.2263420867670982,"['ACTA2', 'ITPKC', 'TIGAR', 'ITPR1', 'CBLB', 'LRRFIP2', 'AEN', 'TRIM22', 'TOPORS', 'PHLDA3', 'DCP1B']",0.9951480220574164,0,0,11
171,DNA damage response (only ATM dependent) WP710,0.3604251755659368,1.123412240817633,1.1464095017795315,"['SMAD4', 'CDKN1B', 'MAP3K1', 'INSR', 'PIK3R4', 'PIK3CB', 'PPP2R5C', 'PIK3C2B', 'CCND3', 'MAPK8', 'CCND1', 'SCP2', 'MYC', 'AKT2', 'DVL2', 'ABL1', 'RAC3', 'ATM', 'KRAS', 'MAP3K7']",0.9951480220574164,0,0,20
172,Vitamin D-sensitive calcium signaling in depression WP4698,0.3691822741244525,1.2238227212713064,1.2194962498310082,"['CYP27A1', 'GRIN2A', 'CHRM1', 'RXRA', 'ITPR1', 'ATP2B4', 'KCNQ3', 'GRIN2B']",0.9951480220574164,0,0,8
173,Initiation of transcription and translation elongation at the HIV-1 LTR WP3414,0.37329717534477286,1.2421379310344827,1.223978445625994,"['HDAC4', 'PPP3CA', 'PPP3CC', 'HDAC1', 'SP1', 'NFATC3', 'HDAC7']",0.9951480220574164,0,0,7
174,Androgen receptor signaling pathway WP138,0.3741518170053214,1.1258121158911325,1.1067787265906948,"['RB1', 'PIAS4', 'SMAD4', 'ROCK1', 'HDAC1', 'RNF6', 'SIRT1', 'PIAS2', 'PTK2', 'NCOR1', 'CCND1', 'ZMIZ1', 'CCNE1', 'SP1', 'ZNF318', 'STUB1', 'RAD9A']",0.9951480220574164,0,0,17
175,Extracellular vesicle-mediated signaling in recipient cells WP2870,0.3772941406879907,1.2674447234943615,1.2354166256471104,"['SMAD2', 'TGFB2', 'SMAD4', 'KRAS', 'MFGE8', 'RAF1']",0.9951480220574164,0,0,6
176,Intraflagellar transport proteins binding to dynein WP4532,0.3772941406879907,1.2674447234943615,1.2354166256471104,"['DYNC2H1', 'WDR60', 'WDR19', 'IFT80', 'IFT46', 'DYNC1I1']",0.9951480220574164,0,0,6
177,Thermogenesis WP4321,0.3787520748322966,1.1092829927260133,1.0769733995945054,"['PRKAA1', 'RPS6', 'ACTL6A', 'ACSL5', 'PRKAG2', 'ACSL4', 'CPT1C', 'SMARCA2', 'ADCY5', 'RPTOR', 'RPS6KA3', 'CREB3', 'RPS6KA6', 'RPS6KB1', 'CNR1', 'PRDM16', 'ZNF516', 'KRAS', 'SLC25A20', 'PPARGC1A']",0.9951480220574164,0,0,20
178,Role of Altered Glycolysation of MUC1 in Tumour Microenvironment WP4480,0.378934846913202,1.7741824440619622,1.7216506699695235,"['IKBKB', 'CHUK']",0.9951480220574164,0,0,2
179,Amino Acid metabolism WP3925,0.37909809057255855,1.1268249026810078,1.092975413001595,"['MPST', 'OAT', 'HIBADH', 'MAOA', 'IDH1', 'MCCC1', 'GOT2', 'DLST', 'EPRS', 'ACLY', 'PKM', 'AUH', 'CPS1', 'ALDH1A1', 'OGDH', 'ALDH18A1']",0.9951480220574164,0,0,16
180,1q21.1 copy number variation syndrome WP4905,0.38096279710497494,1.3046783151579033,1.2590844448918173,"['PYGO1', 'PRKAA1', 'PRKAG2', 'CHD1L', 'TJP2']",0.9951480220574164,0,0,5
181,Nanoparticle triggered autophagic cell death WP2509,0.38096279710497494,1.3046783151579033,1.2590844448918173,"['SH3GLB1', 'INSR', 'ATG10', 'AMBRA1', 'ATG7']",0.9951480220574164,0,0,5
182,Zinc homeostasis WP3529,0.38096279710497494,1.3046783151579033,1.2590844448918173,"['SLC30A7', 'SLC39A6', 'SLC30A1', 'SLC39A12', 'SLC39A14']",0.9951480220574164,0,0,5
183,PI3K-Akt signaling pathway WP4172,0.38130696374372064,1.058731663426469,1.0207767146668096,"['CHRM2', 'ITGB1', 'CDKN1B', 'CHRM1', 'CSF3R', 'ITGB5', 'ITGA2B', 'PPP2R2A', 'PIK3CB', 'RPTOR', 'IKBKB', 'GHR', 'GYS1', 'CCND3', 'PPP2R1B', 'CCND1', 'MYC', 'AKT2', 'CHUK', 'ITGA3', 'RPS6', 'F2R', 'PPP2R5C', 'CREB3', 'CCNE2', 'CCNE1', 'KIT', 'COL6A1', 'COL4A5', 'SGK1', 'RAF1', 'ITGA9', 'PHLPP2', 'PRKAA1', 'PHLPP1', 'LAMA4', 'LAMA3', 'FGF20', 'THEM4', 'EIF4E', 'INSR', 'VEGFD', 'IGF1', 'PTK2', 'EPOR', 'FGF17', 'EFNA3', 'CDK6', 'RPS6KB1', 'PPP2R2B', 'FGF18', 'KRAS']",0.9951480220574164,0,0,52
184,Spinal Cord Injury WP2431,0.3837076640588427,1.1092451523545706,1.062517432533605,"['RB1', 'SEMA6A', 'CDKN1B', 'MIF', 'RTN4', 'EFNB2', 'FKBP1A', 'PPP3CA', 'CCND1', 'CHST11', 'PRB1', 'MYC', 'CCNG1', 'PLXNA2', 'SLIT3', 'SOX9', 'NOS1', 'SLIT2', 'ROS1']",0.9951480220574164,0,0,19
185,15q13.3 copy number variation syndrome WP4942,0.38382796131333474,1.3648480351890617,1.3069250367767837,"['KLF13', 'OTUD7A', 'FYN', 'FAN1']",0.9951480220574164,0,0,4
186,GDNF/RET signaling axis WP4830,0.38382796131333474,1.3648480351890617,1.3069250367767837,"['ROBO2', 'GFRA1', 'SLIT2', 'FAT4']",0.9951480220574164,0,0,4
187,"GPCRs, Class B Secretin-like WP334",0.38382796131333474,1.3648480351890617,1.3069250367767837,"['ADCYAP1R1', 'ADGRL1', 'ADGRL2', 'ADGRL3']",0.9951480220574164,0,0,4
188,Matrix Metalloproteinases WP129,0.38382796131333474,1.3648480351890617,1.3069250367767837,"['MMP16', 'MMP26', 'TIMP2', 'TCF20']",0.9951480220574164,0,0,4
189,Mitochondrial LC-Fatty Acid Beta-Oxidation WP368,0.38382796131333474,1.3648480351890617,1.3069250367767837,"['ACADVL', 'SCP2', 'ACSL4', 'SLC25A20']",0.9951480220574164,0,0,4
190,TGF-B Signaling in Thyroid Cells for Epithelial-Mesenchymal Transition WP3859,0.38382796131333474,1.3648480351890617,1.3069250367767837,"['SMAD2', 'CDH6', 'SMAD4', 'SNAI2']",0.9951480220574164,0,0,4
191,Genes targeted by miRNAs in adipocytes WP1992,0.3846334268571018,1.4785353535353536,1.4126880959676353,"['HDAC4', 'IGF1', 'ERG']",0.9951480220574164,0,0,3
192,NO metabolism in cystic fibrosis WP4947,0.3846334268571018,1.4785353535353536,1.4126880959676353,"['DDAH1', 'PRMT1', 'NOS1']",0.9951480220574164,0,0,3
193,RalA downstream regulated genes WP2290,0.3846334268571018,1.4785353535353536,1.4126880959676353,"['RAC3', 'KRAS', 'EXOC2']",0.9951480220574164,0,0,3
194,Synaptic Vesicle Pathway WP2267,0.3877160963153501,1.1674509020220556,1.106138619488436,"['NSF', 'STX1B', 'SLC1A3', 'CACNA1A', 'AP2A1', 'SYN3', 'STX2', 'CPLX1', 'DNM2', 'CPLX3']",0.9951480220574164,0,0,10
195,Nuclear Receptors Meta-Pathway WP2882,0.38902553326073874,1.0588388768591814,0.999660688958272,"['SLC26A2', 'CDKN1B', 'SRXN1', 'GSTP1', 'ABHD2', 'AMIGO2', 'CUL1', 'IRS2', 'SLC5A2', 'SLC6A1', 'AGER', 'CYP3A5', 'AKAP13', 'EPB41L4B', 'RXRA', 'SCP2', 'CCND1', 'MYC', 'DNER', 'ENC1', 'SLC39A6', 'ME1', 'STOM', 'POLK', 'PPARGC1A', 'SRGN', 'TGFB2', 'SLC10A1', 'NCOA6', 'AIP', 'ARNT', 'SLC39A12', 'SMC1A', 'SLC39A14', 'SLC6A7', 'GPAM', 'NAV3', 'SP1', 'ADGRF4', 'BHLHE40', 'ALOX5AP', 'SNAI2', 'BLVRB', 'MFGE8', 'PPARA', 'HBEGF', 'FTL']",0.9951480220574164,0,0,47
196,Melanoma WP4685,0.39537034565368184,1.1308522026640648,1.049354363864839,"['RB1', 'SHC2', 'MITF', 'PIK3CB', 'GRIN2A', 'CDK6', 'CCND1', 'AKT2', 'KIT', 'NF1', 'KRAS', 'POLK', 'RAF1']",0.9951480220574164,0,0,13
197,Primary focal segmental glomerulosclerosis (FSGS) WP2572,0.39537034565368184,1.1308522026640648,1.049354363864839,"['ITGB1', 'SMARCAL1', 'CDKN1B', 'TRPC6', 'ITGA3', 'PTPRO', 'ILK', 'PTK2', 'LRP6', 'COL4A5', 'FYN', 'UTRN', 'LIMS1']",0.9951480220574164,0,0,13
198,Sterol regulatory element-binding proteins (SREBP) signaling WP1982,0.39537034565368184,1.1308522026640648,1.049354363864839,"['GSK3A', 'PRKAA1', 'SEC24A', 'NR1H2', 'PRKAG2', 'SIRT1', 'ACLY', 'SQLE', 'GPAM', 'SP1', 'LPIN1', 'ATF6', 'KPNB1']",0.9951480220574164,0,0,13
199,ATM Signaling Pathway WP2516,0.3995523552426478,1.182936644820053,1.0852384638260726,"['RAD50', 'MRE11', 'CCNE1', 'ABL1', 'MDM4', 'ATM', 'SMC1A', 'RAD9A']",0.9951480220574164,0,0,8
200,Ferroptosis WP4313,0.3995523552426478,1.182936644820053,1.0852384638260726,"['TF', 'VDAC3', 'ACSL5', 'SAT2', 'ACSL4', 'ATG7', 'SLC39A14', 'FTL']",0.9951480220574164,0,0,8
201,T-cell receptor (TCR) signaling pathway WP69,0.4058264098128772,1.109094052558783,1.0002140374865576,"['FYB1', 'CHUK', 'ITPR1', 'CBLB', 'OPRM1', 'GAB2', 'CBL', 'MALT1', 'IKBKB', 'MAPK8', 'MAP3K8', 'FYN', 'RAF1', 'MAP3K7', 'MAP3K14']",0.9951480220574164,0,0,15
202,Amyotrophic lateral sclerosis (ALS) WP2447,0.4060596748103471,1.1942705570291776,1.0763424874957028,"['GRIA1', 'PPP3CA', 'PPP3CC', 'APAF1', 'NEFM', 'NOS1', 'MAP2K6']",0.9951480220574164,0,0,7
203,Target Of Rapamycin (TOR) Signaling WP1471,0.4060596748103471,1.1942705570291776,1.0763424874957028,"['RPTOR', 'FKBP1A', 'PRKAA1', 'RRAGA', 'RPS6KB1', 'ULK3', 'PRKAG2']",0.9951480220574164,0,0,7
204,DNA IR-double strand breaks and cellular response via ATM WP3959,0.4077688875730259,1.1348210844147502,1.0179966068381459,"['LATS1', 'RAD52', 'RAD50', 'MRE11', 'APAF1', 'ACTL6A', 'ABL1', 'ATM', 'SMC3', 'SMC1A', 'RAD9A']",0.9951480220574164,0,0,11
205,Chromosomal and microsatellite instability in colorectal cancer  WP4216,0.412077101980525,1.1090563428966471,0.9832281408131124,"['SMAD2', 'TGFB2', 'SMAD4', 'RALB', 'DCC', 'MAPK8', 'CCND1', 'MYC', 'AKT2', 'RAC3', 'KRAS', 'POLK', 'RAF1', 'EXOC2']",0.9951480220574164,0,0,14
206,PI3K-AKT-mTOR signaling pathway and therapeutic opportunities WP3844,0.4130665110740246,1.2097395882297641,1.0695872106259947,"['RPTOR', 'CDKN1B', 'TFEB', 'KRAS', 'FOXO4', 'PIK3CB']",0.9951480220574164,0,0,6
207,EPO Receptor Signaling WP581,0.42068944412324427,1.232100467110805,1.066826978554197,"['CISH', 'RASA1', 'IRS2', 'RAF1', 'EPOR']",0.9951480220574164,0,0,5
208,Apoptosis Modulation and Signaling WP1772,0.4274606438862794,1.0908271546153323,0.9270864239251938,"['ENDOG', 'APAF1', 'TRADD', 'HTRA2', 'TNFRSF1B', 'PTPN13', 'IKBKB', 'MAPK8', 'TRAF3', 'TOLLIP', 'MADD', 'BIRC6', 'TNFRSF25', 'PRKD1', 'MAP3K14']",0.9951480220574164,0,0,15
209,Adipogenesis WP236,0.4281428971644302,1.0708175018519845,0.908372631355206,"['RB1', 'CNTFR', 'CEBPA', 'EPAS1', 'CELF1', 'GTF3A', 'HMGA1', 'IRS2', 'MIF', 'IGF1', 'KLF15', 'BMP1', 'RBL1', 'NCOR1', 'RXRA', 'KLF5', 'SP1', 'ID3', 'PPARA', 'LPIN1', 'PPARGC1A']",0.9951480220574164,0,0,21
210,IL1 and megakaryocytes in obesity WP2865,0.4290895885665386,1.2672604694650853,1.0722158412281635,"['F2R', 'IL18', 'TIMP2', 'HBEGF']",0.9951480220574164,0,0,4
211,Inhibition of exosome biogenesis and secretion by Manumycin A in CRPC cells WP4301,0.4290895885665386,1.2672604694650853,1.0722158412281635,"['RAB5B', 'RRAS2', 'KRAS', 'RAF1']",0.9951480220574164,0,0,4
212,Nicotine Activity on Dopaminergic Neurons WP1602,0.4290895885665386,1.2672604694650853,1.0722158412281635,"['CHRNB2', 'PPP1R1B', 'GNAI1', 'KCNK3']",0.9951480220574164,0,0,4
213,Simplified Interaction Map Between LOXL4 and Oxidative Stress Pathway WP3670,0.4290895885665386,1.2672604694650853,1.0722158412281635,"['ANXA5', 'IGFBP7', 'NRF1', 'SIRT1']",0.9951480220574164,0,0,4
214,Regulation of toll-like receptor signaling pathway WP1449,0.43438902209352936,1.0689380313077734,0.891296331659146,"['CUEDC2', 'CISH', 'CHUK', 'PELI3', 'SFTPD', 'PIK3CB', 'IKBKB', 'MAPK8', 'RNF216', 'TRAF3', 'AKT2', 'TOLLIP', 'PELI1', 'SARM1', 'MAP3K8', 'CD14', 'MAP2K7', 'MAP3K7', 'IKBKE', 'MAP2K6']",0.9951480220574164,0,0,20
215,Development and heterogeneity of the ILC family WP3893,0.4384749970095469,1.3305785123966942,1.0969987652351016,"['IL5', 'IL18', 'TOX']",0.9951480220574164,0,0,3
216,Nephrogenesis WP5052,0.4384749970095469,1.3305785123966942,1.0969987652351016,"['NOTCH2', 'MEIS1', 'FGF20']",0.9951480220574164,0,0,3
217,Regulation of sister chromatid separation at the metaphase-anaphase transition WP4240,0.4384749970095469,1.3305785123966942,1.0969987652351016,"['SMC1A', 'SMC3', 'MAD1L1']",0.9951480220574164,0,0,3
218,Tryptophan metabolism WP465,0.4387362709340209,1.149948914431673,0.947393228218989,"['ALDH3A2', 'PRMT1', 'ALDH1A1', 'OGDH', 'DHCR24', 'CYP7B1', 'HSD17B10']",0.9951480220574164,0,0,7
219,Neural Crest Differentiation WP2064,0.44171493217706775,1.075354024506567,0.8786616164901438,"['NOTCH2', 'ITGB1', 'HDAC4', 'CTBP2', 'HDAC1', 'COL11A2', 'MITF', 'TBX6', 'HDAC7', 'CDH6', 'GJB1', 'LHX2', 'MYC', 'DVL2', 'SNAI2', 'SOX9']",0.9951480220574164,0,0,16
220,Heart Development WP1591,0.44860384249207624,1.157052290814262,0.9275105778708684,"['SMAD4', 'BMPR2', 'BHLHE40', 'NFATC3', 'SMYD1', 'BMPR1A']",0.9951480220574164,0,0,6
221,Estrogen metabolism WP697,0.44892278793120993,1.478370625358577,1.184033495136418,"['COMT', 'ARSD']",0.9951480220574164,0,0,2
222,Irinotecan pathway WP229,0.44892278793120993,1.478370625358577,1.184033495136418,"['ABCC1', 'CYP3A5']",0.9951480220574164,0,0,2
223,TFs regulate miRNAs related to cardiac hypertrophy WP1559,0.44892278793120993,1.478370625358577,1.184033495136418,"['MYEF2', 'AKT2']",0.9951480220574164,0,0,2
224,Urea cycle and related diseases WP4571,0.44892278793120993,1.478370625358577,1.184033495136418,"['SLC25A15', 'CPS1']",0.9951480220574164,0,0,2
225,Vitamin D Metabolism WP1531,0.44892278793120993,1.478370625358577,1.184033495136418,"['CYP27A1', 'RXRA']",0.9951480220574164,0,0,2
226,Prolactin Signaling Pathway WP2037,0.4569496998893785,1.070646149445153,0.8385107498244544,"['ITGB1', 'CISH', 'RPS6', 'IRS2', 'PIK3CB', 'GAB2', 'CBL', 'PTK2', 'SOCS2', 'MAPK8', 'RPS6KB1', 'MYC', 'FYN', 'RAF1']",0.9951480220574164,0,0,14
227,miRNAs involvement in the immune response in sepsis WP4329,0.4599322758154111,1.1671623925423482,0.9065070497006551,"['IKBKB', 'MAPK8', 'CHUK', 'TRAF3', 'MAP3K7']",0.9951480220574164,0,0,5
228,Signal Transduction of S1P Receptor WP26,0.4599322758154111,1.1671623925423482,0.9065070497006551,"['AKT2', 'GNAI3', 'MAPK6', 'GNAI1', 'PIK3C2B']",0.9951480220574164,0,0,5
229,T-Cell Receptor and Co-stimulatory Signaling WP2583,0.4599322758154111,1.1671623925423482,0.9065070497006551,"['PPP3CA', 'GSK3A', 'CD8B', 'RASA1', 'FYN']",0.9951480220574164,0,0,5
230,Aryl Hydrocarbon Receptor Netpath WP2586,0.4601453141370974,1.1088306312521559,0.860688683233876,"['RB1', 'CDKN1B', 'MYC', 'AIP', 'NF1', 'ARNT', 'KRAS', 'RAF1']",0.9951480220574164,0,0,8
231,TGF-beta Signaling Pathway WP366,0.46170076118997155,1.043684070922854,0.8065990239468092,"['NUP214', 'SMAD2', 'ITGB1', 'SMAD4', 'ROCK1', 'ZFYVE9', 'HDAC1', 'CUL1', 'NUP153', 'PIAS2', 'PTK2', 'MAPK8', 'ITCH', 'RBL1', 'PARD6A', 'CCND1', 'SP1', 'MYC', 'BTRC', 'RAF1', 'DCP1A', 'MAP3K7', 'SPTBN1', 'MAP2K6']",0.9951480220574164,0,0,24
232,Neural Crest Cell Migration in Cancer WP4565,0.4711150960519613,1.1087931034482759,0.834536288846525,"['TIAM1', 'KIDINS220', 'AKT2', 'PIK3R4', 'PIK3CB', 'PAK3', 'PAK5']",0.9951480220574164,0,0,7
233,Hematopoietic Stem Cell Gene Regulation by GABP alpha/beta Complex WP3657,0.47341092982111826,1.1826845791709726,0.8844014686837697,"['SMAD4', 'DNMT1', 'ATM', 'ETV6']",0.9951480220574164,0,0,4
234,GABA receptor Signaling WP4159,0.4836445004092582,1.1087556015167184,0.8054057739681421,"['GABRB3', 'GABRB2', 'GAD2', 'AP2A1', 'SLC6A1', 'GPHN']",0.9951480220574164,0,0,6
235,Nucleotide-binding Oligomerization Domain (NOD) pathway WP1433,0.4836445004092582,1.1087556015167184,0.8054057739681421,"['IKBKB', 'AIM2', 'CHUK', 'IL18', 'NLRC4', 'NLRP1']",0.9951480220574164,0,0,6
236,Tumor suppressor activity of SMARCB1 WP4204,0.4836445004092582,1.1087556015167184,0.8054057739681421,"['RB1', 'GLI4', 'CDK6', 'EED', 'H3F3A', 'ACTL6A']",0.9951480220574164,0,0,6
237,Ras signaling WP4223,0.48690690345600746,1.0235020453998556,0.736596344477867,"['SHC2', 'RAB5B', 'RALB', 'FOXO4', 'PIK3CB', 'IKBKB', 'GRIN2A', 'MAPK8', 'AKT2', 'ABL1', 'RAC3', 'PAK3', 'PAK5', 'PLA2G12A', 'KSR1', 'CHUK', 'INSR', 'RRAS2', 'KSR2', 'GAB2', 'GRIN2B', 'TIAM1', 'RASA1', 'KIT', 'RASA2', 'NF1', 'KRAS', 'RAF1', 'EXOC2', 'ARF6']",0.9951480220574164,0,0,30
238,Splicing factor NOVA regulated synaptic proteins WP4148,0.4900298717334923,1.0751460796303847,0.7668897935230841,"['KCNJ6', 'KCNMA1', 'CASK', 'ANK3', 'STX2', 'GRIN2B', 'GPHN', 'CLASP1']",0.9951480220574164,0,0,8
239,Leptin Insulin Overlap WP3935,0.4903988797240106,1.2095229151014275,0.861828836067711,"['SOCS2', 'INSR', 'IRS2']",0.9951480220574164,0,0,3
240,Mammalian disorder of sexual development WP4842,0.4903988797240106,1.2095229151014275,0.861828836067711,"['EMX2', 'SOX9', 'PBX1']",0.9951480220574164,0,0,3
241,Mammary gland development pathway - Embryonic development (Stage 1 of 4) WP2813,0.4903988797240106,1.2095229151014275,0.861828836067711,"['ITGB1', 'CCND1', 'MYC']",0.9951480220574164,0,0,3
242,Omega-9 FA synthesis WP4724,0.4903988797240106,1.2095229151014275,0.861828836067711,"['ACOT2', 'ELOVL6', 'ACSL4']",0.9951480220574164,0,0,3
243,"GPCRs, Class A Rhodopsin-like WP455",0.49548090873456485,1.0234531337549027,0.7186958662300711,"['OPRD1', 'CHRM2', 'CHRM3', 'NPFFR1', 'RABGAP1', 'P2RY11', 'CHRM1', 'HTR1F', 'P2RY14', 'NPY2R', 'F2R', 'GPR52', 'OPRL1', 'OPRM1', 'ADRA1A', 'SSTR3', 'ADRA2A', 'HCRTR1', 'OPN1SW', 'MC1R', 'HRH3', 'ADORA2A', 'CNR1', 'DRD5']",0.9951480220574164,0,0,24
244,Cell migration and invasion through p75NTR WP4561,0.498359548306109,1.1087181254307374,0.7721484201183894,"['EFNB2', 'TIAM1', 'EFNA3', 'KIDINS220', 'AKT2']",0.9951480220574164,0,0,5
245,Ethanol effects on histone modifications WP3996,0.498359548306109,1.1087181254307374,0.7721484201183894,"['HDAC4', 'AHCY', 'HDAC1', 'ALDH1A1', 'HDAC7']",0.9951480220574164,0,0,5
246,Thyroid stimulating hormone (TSH) signaling pathway WP2032,0.49837585270971174,1.0435029970537437,0.7266962826126205,"['RB1', 'CCND3', 'CDKN1B', 'RPS6KB1', 'CCNE1', 'MYC', 'GNAQ', 'RPS6', 'GNAI3', 'RAF1', 'GNAI1', 'MAP2K6']",0.9951480220574164,0,0,12
247,Ciliary landscape WP4352,0.5029826185791937,1.011445105091879,0.6950647373729062,"['RB1', 'WDR26', 'RALB', 'CTBP2', 'HDAC1', 'IFT172', 'SSNA1', 'VPS4A', 'USH1C', 'HTRA2', 'EHBP1', 'MAEA', 'STOM', 'NEFM', 'TMED1', 'NINL', 'CEP290', 'CDR2', 'BBS2', 'IQCB1', 'RNGTT', 'H3F3A', 'NEK7', 'RANBP9', 'IFT80', 'ARMC8', 'MYL6', 'RABEP2', 'WDR60', 'GLB1', 'GID8', 'EXOC4', 'MCM3', 'CD2BP2', 'EXOC3', 'IFT46', 'EXOC2', 'ARL8B', 'MCM2']",0.9951480220574164,0,0,39
248,Exercise-induced Circadian Regulation WP410,0.5063854611208065,1.0503432494279177,0.7147135412896137,"['NCKAP1', 'GSTP1', 'ZFR', 'KLF9', 'CRY1', 'GFRA1', 'QKI', 'ARNTL', 'ETV6']",0.9951480220574164,0,0,9
249,AGE/RAGE pathway WP2324,0.5091044770385329,1.0379173033972022,0.700700072358079,"['IKBKB', 'SMAD2', 'MAPK8', 'CHUK', 'ROCK1', 'SP1', 'INSR', 'INHBB', 'FOXO4', 'RAF1', 'AGER']",0.9951480220574164,0,0,11
250,Association Between Physico-Chemical Features and Toxicity Associated Pathways WP3680,0.5091044770385329,1.0379173033972022,0.700700072358079,"['GRIA1', 'MAPK8', 'CDKN1B', 'MYC', 'FZD7', 'FZD6', 'NEFM', 'NOS1', 'RAF1', 'CBL', 'PTK2']",0.9951480220574164,0,0,11
251,Apoptosis WP254,0.5114128100987652,1.0294821798795537,0.69034827351365,"['MAP3K1', 'APAF1', 'CHUK', 'TRADD', 'IGF1', 'TNFRSF1B', 'IKBKB', 'TRAF3', 'MYC', 'IRF2', 'TNFRSF25', 'NFKBIE', 'TNFRSF21']",0.9951480220574164,0,0,13
252,Leptin and adiponectin WP3934,0.5141924299608073,1.2670764691418737,0.842805677836258,"['PRKAA1', 'ADIPOR1']",0.9951480220574164,0,0,2
253,Methionine metabolism leading to sulfur amino acids and related disorders WP4292,0.5141924299608073,1.2670764691418737,0.842805677836258,"['AHCY', 'ADK']",0.9951480220574164,0,0,2
254,Serotonin Transporter Activity WP1455,0.5141924299608073,1.2670764691418737,0.842805677836258,"['MAOA', 'NOS1']",0.9951480220574164,0,0,2
255,Wnt signaling pathway and pluripotency WP399,0.5152630417433871,1.0187599364069952,0.6755170444316875,"['CTBP2', 'PRKCE', 'FZD7', 'LRRK2', 'FZD6', 'PPP2R2A', 'PPM1J', 'PPP2R5C', 'LRP6', 'CCND3', 'CCND1', 'PPP2R1B', 'PPP2R2B', 'MYC', 'DVL2', 'PRKD1', 'MAP3K7']",0.9951480220574164,0,0,17
256,Hippo-Yap signaling pathway WP4537,0.5163588147825143,1.1086806751636238,0.7327862370157009,"['LATS1', 'STK38L', 'YY1AP1', 'MAP4K4']",0.9951480220574164,0,0,4
257,"Relationship between inflammation, COX-2 and EGFR WP4483",0.5163588147825143,1.1086806751636238,0.7327862370157009,"['PTGES2', 'AKT2', 'KRAS', 'PIK3CB']",0.9951480220574164,0,0,4
258,Triacylglyceride synthesis WP325,0.5163588147825143,1.1086806751636238,0.7327862370157009,"['GPAM', 'AGPS', 'PLPP3', 'AGPAT4']",0.9951480220574164,0,0,4
259,Urea cycle and metabolism of amino groups WP497,0.5163588147825143,1.1086806751636238,0.7327862370157009,"['OAT', 'CPS1', 'CKB', 'ALDH18A1']",0.9951480220574164,0,0,4
260,Cardiac Progenitor Differentiation WP2406,0.5179566528899431,1.0643226473629783,0.7001792581007227,"['BMP1', 'TNNT2', 'KIT', 'NCAM1', 'THY1', 'IGF1']",0.9951480220574164,0,0,6
261,Wnt signaling in kidney disease WP4150,0.5179566528899431,1.0643226473629783,0.7001792581007227,"['INVS', 'MAPK8', 'FZD7', 'FZD6', 'DVL2', 'LRP6']",0.9951480220574164,0,0,6
262,Integrated Cancer Pathway WP1971,0.5194365134584489,1.0434429722216585,0.6834662938234662,"['RB1', 'SMAD2', 'RAD50', 'MRE11', 'CDKN1B', 'MYC', 'ATM', 'CDC25B']",0.9951480220574164,0,0,8
263,PPAR signaling pathway WP3942,0.5208291243224155,1.031299419608095,0.6727509200331431,"['CYP27A1', 'RXRA', 'SCP2', 'ME1', 'ILK', 'ACSL5', 'ACSL4', 'SORBS1', 'CPT1C', 'PPARA']",0.9951480220574164,0,0,10
264,Cytosolic DNA-sensing pathway WP4655,0.5337706860928362,1.0233317407230451,0.64243636826569,"['IKBKB', 'AIM2', 'CHUK', 'DDX58', 'TRADD', 'POLR1C', 'IL18', 'POLR3H', 'IKBKE']",0.9951480220574164,0,0,9
265,G13 Signaling Pathway WP524,0.5342280315746326,1.0347126436781608,0.6486949904330692,"['ROCK1', 'RPS6KB1', 'CFL2', 'ARHGDIG', 'PIK3CB', 'PAK3', 'CIT']",0.9951480220574164,0,0,7
266,Oxidation by Cytochrome P450 WP43,0.5342280315746326,1.0347126436781608,0.6486949904330692,"['CYP27A1', 'CYB5B', 'CYB5R4', 'CYP2U1', 'CYP4V2', 'CYP7B1', 'CYP3A5']",0.9951480220574164,0,0,7
267,Oxidative Damage WP3941,0.5342280315746326,1.0347126436781608,0.6486949904330692,"['C1QA', 'CDKN1B', 'MAP3K1', 'APAF1', 'TRAF3', 'TNFRSF1B', 'NFKBIE']",0.9951480220574164,0,0,7
268,Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4) WP2817,0.5356890362900749,1.0558399789964228,0.6590568378777942,"['CEBPA', 'CCND1', 'CHUK', 'MYC', 'EIF4E']",0.9951480220574164,0,0,5
269,Toll-like Receptor Signaling related to MyD88 WP3858,0.5356890362900749,1.0558399789964228,0.6590568378777942,"['IKBKB', 'CHUK', 'TRAF3', 'TOLLIP', 'IKBKE']",0.9951480220574164,0,0,5
270,ERK Pathway in Huntington's Disease WP3853,0.5398306895138643,1.1086432506887052,0.6834782608627098,"['RAF1', 'MAP2K7', 'GRM1']",0.9951480220574164,0,0,3
271,Hypertrophy Model WP516,0.5398306895138643,1.1086432506887052,0.6834782608627098,"['IL18', 'EIF4E', 'HBEGF']",0.9951480220574164,0,0,3
272,MAP3K1 role in promoting and blocking gonadal determination WP4872,0.5398306895138643,1.1086432506887052,0.6834782608627098,"['MAP3K1', 'ROCK1', 'SOX9']",0.9951480220574164,0,0,3
273,Overview of nanoparticle effects WP3287,0.5398306895138643,1.1086432506887052,0.6834782608627098,"['CCND3', 'LAMA3', 'PTK2']",0.9951480220574164,0,0,3
274,TP53 network WP1742,0.5398306895138643,1.1086432506887052,0.6834782608627098,"['MYC', 'ABL1', 'ATM']",0.9951480220574164,0,0,3
275,Acute viral myocarditis WP4298,0.5455685654815657,1.0039691074396324,0.6083317772241406,"['ENDOG', 'CHRAC1', 'CCND1', 'RASA1', 'JKAMP', 'ABL1', 'ILK', 'RAC3', 'DMD', 'FYN', 'NOS1', 'EIF4G1']",0.9951480220574164,0,0,12
276,ATM Signaling Network in Development and Disease  WP3878,0.5482313167910314,1.0135514709505742,0.6092031897876464,"['HDAC4', 'PRKAA1', 'RAD50', 'MRE11', 'ATM', 'CEP63', 'SMC1A', 'LBR']",0.9951480220574164,0,0,8
277,Peptide GPCRs WP24,0.5482313167910314,1.0135514709505742,0.6092031897876464,"['OPRD1', 'MC1R', 'ATP8A1', 'NPY2R', 'OPRL1', 'OPRM1', 'SSTR3', 'HCRTR1']",0.9951480220574164,0,0,8
278,Fatty acid beta-oxidation WP143,0.5513395910658996,1.023307612759526,0.6092817957885709,"['HADHB', 'ACADVL', 'GPD2', 'ACSL5', 'ACSL4', 'SLC25A20']",0.9951480220574164,0,0,6
279,Mitochondrial CIV Assembly WP4922,0.5513395910658996,1.023307612759526,0.6092817957885709,"['COX8A', 'SURF1', 'SCO2', 'COX17', 'CMC1', 'COX10']",0.9951480220574164,0,0,6
280,Neural Crest Cell Migration during Development WP4564,0.5513395910658996,1.023307612759526,0.6092817957885709,"['TIAM1', 'AKT2', 'PIK3R4', 'PIK3CB', 'PAK3', 'PAK5']",0.9951480220574164,0,0,6
281,mRNA Processing WP411,0.5536392662872831,0.9900657124005224,0.5853683806525121,"['SRPK2', 'RBM39', 'RNGTT', 'DHX9', 'CELF1', 'PRMT1', 'SFSWAP', 'CELF2', 'CPSF2', 'CELF4', 'PRPF40A', 'DICER1', 'SMC1A', 'PRPF3', 'DHX15', 'SPOP', 'CD2BP2', 'SRSF3', 'DHX38', 'SRSF4', 'RNPS1', 'HNRNPH2', 'RBM5']",0.9951480220574164,0,0,23
282,Activation of NLRP3 Inflammasome by SARS-CoV-2 WP4876,0.5567216012908244,1.4782060105528791,0.865770451941995,['TRAF3'],0.9951480220574164,0,0,1
283,Aflatoxin B1 metabolism WP699,0.5567216012908244,1.4782060105528791,0.865770451941995,['EPHX1'],0.9951480220574164,0,0,1
284,Effects of nitric oxide WP1995,0.5567216012908244,1.4782060105528791,0.865770451941995,['NOS1'],0.9951480220574164,0,0,1
285,Nanomaterial-induced inflammasome activation WP3890,0.5567216012908244,1.4782060105528791,0.865770451941995,['CTSB'],0.9951480220574164,0,0,1
286,SARS-CoV-2 altering angiogenesis via NRP1 WP5065,0.5567216012908244,1.4782060105528791,0.865770451941995,['NRP1'],0.9951480220574164,0,0,1
287,Secretion of Hydrochloric Acid in Parietal Cells WP2597,0.5567216012908244,1.4782060105528791,0.865770451941995,['CHRM1'],0.9951480220574164,0,0,1
288,Steroid Biosynthesis WP496,0.5567216012908244,1.4782060105528791,0.865770451941995,['HSD17B4'],0.9951480220574164,0,0,1
289,Thyroxine (Thyroid Hormone) Production WP1981,0.5567216012908244,1.4782060105528791,0.865770451941995,['TG'],0.9951480220574164,0,0,1
290,Vitamin B6-dependent and responsive disorders WP4228,0.5567216012908244,1.4782060105528791,0.865770451941995,['AASS'],0.9951480220574164,0,0,1
291,IL-7 signaling pathway WP205,0.5575886794638829,1.0433831128041986,0.6094752611486669,"['CDKN1B', 'CCND1', 'MYC', 'FYN']",0.9951480220574164,0,0,4
292,Regulation of apoptosis by parathyroid hormone-related protein WP3872,0.5575886794638829,1.0433831128041986,0.6094752611486669,"['BCL2L13', 'GSK3A', 'MYC', 'BCL2L15']",0.9951480220574164,0,0,4
293,Fas ligand pathway and stress induction of heat shock proteins WP314,0.5646386512717756,1.0012569521690768,0.5722877429907067,"['RB1', 'MAPK8', 'MAP3K1', 'APAF1', 'FAF1', 'MAPKAPK2', 'MAP3K7']",0.9951480220574164,0,0,7
294,Glycolysis and Gluconeogenesis WP534,0.5646386512717756,1.0012569521690768,0.5722877429907067,"['LDHB', 'PKM', 'GOT2', 'ALDOC', 'ENO1', 'ALDOB', 'GAPDH']",0.9951480220574164,0,0,7
295,IL17 signaling pathway WP2112,0.5716878545012508,1.0077689367834095,0.5635062408293667,"['IKBKB', 'TRAF3', 'SP1', 'MAP3K7', 'MAP3K14']",0.9951480220574164,0,0,5
296,Lipid Metabolism Pathway WP3965,0.5716878545012508,1.0077689367834095,0.5635062408293667,"['ACLY', 'PRKAA1', 'AKT2', 'HILPDA', 'PRKAG2']",0.9951480220574164,0,0,5
297,Nanoparticle-mediated activation of receptor signaling WP2643,0.5716878545012508,1.0077689367834095,0.5635062408293667,"['ITGB1', 'MAPK8', 'KRAS', 'RAF1', 'PTK2']",0.9951480220574164,0,0,5
298,Resistin as a regulator of inflammation WP4481,0.5716878545012508,1.0077689367834095,0.5635062408293667,"['IKBKB', 'CHUK', 'AKT2', 'ITPR1', 'PIK3CB']",0.9951480220574164,0,0,5
299,Autosomal recessive Osteopetrosis pathways WP4788,0.5741099185469907,1.108605851979346,0.6152035291459715,"['IKBKB', 'CLCN7']",0.9951480220574164,0,0,2
300,Dopamine metabolism WP2436,0.5741099185469907,1.108605851979346,0.6152035291459715,"['MAOA', 'COMT']",0.9951480220574164,0,0,2
301,EDA signaling in hair follicle development WP3930,0.5741099185469907,1.108605851979346,0.6152035291459715,"['BMP1', 'SOSTDC1']",0.9951480220574164,0,0,2
302,Ethanol metabolism resulting in production of ROS by CYP2E1 WP4269,0.5741099185469907,1.108605851979346,0.6152035291459715,"['MAPK8', 'SP1']",0.9951480220574164,0,0,2
303,LTF danger signal response pathway WP4478,0.5741099185469907,1.108605851979346,0.6152035291459715,"['CD14', 'AGER']",0.9951480220574164,0,0,2
304,Mammary gland development pathway - Puberty (Stage 2 of 4) WP2814,0.5741099185469907,1.108605851979346,0.6152035291459715,"['CCND1', 'MYC']",0.9951480220574164,0,0,2
305,Selective expression of chemokine receptors during T-cell polarization WP4494,0.5741099185469907,1.108605851979346,0.6152035291459715,"['TGFB2', 'IL5']",0.9951480220574164,0,0,2
306,Cholesterol metabolism (includes both Bloch and Kandutsch-Russell pathways) WP4718,0.5762960740126282,0.9853206086389943,0.5430434252064494,"['CYP27A1', 'SQLE', 'EBP', 'NR1H2', 'ACOT2', 'DHCR24', 'ACSL4', 'LBR']",0.9951480220574164,0,0,8
307,Breast cancer pathway WP4262,0.577910370741253,0.9761238770775854,0.535244340811549,"['RB1', 'NOTCH2', 'SHC2', 'MRE11', 'FZD7', 'FZD6', 'IGF1', 'LRP6', 'FGF17', 'RAD50', 'CDK6', 'CCND1', 'RPS6KB1', 'SP1', 'MYC', 'AKT2', 'FGF18', 'KIT', 'DVL2', 'FGF20', 'ATM', 'KRAS', 'POLK', 'RAF1']",0.9951480220574164,0,0,24
308,Toll-like Receptor Signaling Pathway WP75,0.5782879600356337,0.9769072189099598,0.5350358022869829,"['CHUK', 'PIK3CB', 'IKBKB', 'MAPK8', 'TRAF3', 'AKT2', 'TOLLIP', 'MAP3K8', 'CD14', 'MAP2K7', 'MAP3K7', 'IKBKE', 'MAP2K6']",0.9951480220574164,0,0,13
309,Wnt signaling WP428,0.582212171449547,0.9731783299141402,0.526411954975797,"['INVS', 'CTBP2', 'RYK', 'SERPINF1', 'FZD7', 'CHD8', 'FZD6', 'NFATC3', 'LRP6', 'VANGL1', 'PPP3CA', 'CCND3', 'MAPK8', 'PPP3CC', 'CCND1', 'MYC', 'DVL2', 'MAP3K7']",0.9951480220574164,0,0,18
310,SARS coronavirus and innate immunity WP4912,0.5863722309322296,1.023283534647171,0.5462292467743622,"['DDX58', 'TRAF3', 'IKBKE']",0.9951480220574164,0,0,3
311,Serotonin and anxiety WP3947,0.5863722309322296,1.023283534647171,0.5462292467743622,"['PPP3CA', 'ADRA1A', 'GRM1']",0.9951480220574164,0,0,3
312,Hepatitis B infection WP4666,0.5866035164088489,0.9710554124562446,0.5179669075315485,"['SMAD2', 'TGFB2', 'SMAD4', 'MAP3K1', 'APAF1', 'CHUK', 'SLC10A1', 'DDX58', 'NFATC3', 'PIK3CB', 'IKBKB', 'CREB3', 'MAPK8', 'TRAF3', 'MYC', 'AKT2', 'VDAC3', 'KRAS', 'RAF1', 'MAP2K7', 'MAP3K7', 'IKBKE', 'MAP2K6']",0.9951480220574164,0,0,23
313,DNA IR-damage and cellular response via ATR WP4016,0.5873193272628938,0.969819391634981,0.5161248927205169,"['SMARCAL1', 'MRE11', 'POLN', 'XPA', 'SMC1A', 'RAD52', 'BRIP1', 'RAD50', 'HERC2', 'SP1', 'USP1', 'ATM', 'MCM2', 'RAD9A']",0.9951480220574164,0,0,14
314,Follicle Stimulating Hormone (FSH) signaling pathway WP2035,0.5968388488862123,0.9853408351513759,0.5085424226340509,"['RPS6KB1', 'RPS6', 'SGK1', 'RAF1']",0.9951480220574164,0,0,4
315,NRF2-ARE regulation WP4357,0.5968388488862123,0.9853408351513759,0.5085424226340509,"['MAPK8', 'YES1', 'INSR', 'FYN']",0.9951480220574164,0,0,4
316,Photodynamic therapy-induced NFE2L2 (NRF2) survival signaling WP3612,0.5968388488862123,0.9853408351513759,0.5085424226340509,"['MAPK8', 'SRXN1', 'GSTP1', 'EPHX1']",0.9951480220574164,0,0,4
317,Apoptosis-related network due to altered Notch3 in ovarian cancer WP2864,0.61213764356322,0.9500147885241053,0.4662654664557382,"['CDKN1B', 'RPS6KB1', 'HDAC1', 'F2R', 'ANXA5', 'CUL1', 'ABL1', 'TNFRSF21', 'PTK2']",0.9951480220574164,0,0,9
318,Novel intracellular components of RIG-I-like receptor (RLR) pathway WP3865,0.61213764356322,0.9500147885241053,0.4662654664557382,"['IKBKB', 'MAPK8', 'MAP3K1', 'CHUK', 'DDX58', 'TRAF3', 'TRADD', 'MAP3K7', 'IKBKE']",0.9951480220574164,0,0,9
319,16p11.2 proximal deletion syndrome WP4949,0.61309025077312,0.9499629903774981,0.46476286287122714,"['CCT2', 'KMT2D', 'HIRA', 'PAXIP1', 'PPP4R2', 'KMT2C', 'TCP1', 'PPP4R3A', 'PPP4R3B', 'TBX6', 'BPTF', 'MAP2K6']",0.9951480220574164,0,0,12
320,MET in type 1 papillary renal cell carcinoma WP4205,0.620096733609965,0.9432354820467248,0.45075317517670205,"['MAPK8', 'AKT2', 'KRAS', 'STRN', 'PIK3CB', 'RAF1', 'CBL', 'PAK3', 'PAK5', 'PTK2']",0.9951480220574164,0,0,10
321,Notch Signaling Pathway Netpath WP61,0.620096733609965,0.9432354820467248,0.45075317517670205,"['NOTCH2', 'SPEN', 'ITCH', 'NCOR1', 'CCND1', 'MAML1', 'HDAC1', 'MYC', 'FHL1', 'CUL1']",0.9951480220574164,0,0,10
322,Common Pathways Underlying Drug Addiction WP2636,0.622521582838048,0.9404284221525601,0.44574142345545925,"['GRIA1', 'GRIN2A', 'GJB1', 'RAF1', 'GNAI1', 'GRM1', 'GRIA3']",0.9951480220574164,0,0,7
323,Alanine and aspartate metabolism WP106,0.6284342916217722,0.9853509275196022,0.45771896147521735,"['GOT2', 'GAD2']",0.9951480220574164,0,0,2
324,Cells and molecules involved in local acute inflammatory response  WP4493,0.6284342916217722,0.9853509275196022,0.45771896147521735,"['ITGB1', 'C3']",0.9951480220574164,0,0,2
325,"NAD metabolism, sirtuins and aging WP3630",0.6284342916217722,0.9853509275196022,0.45771896147521735,"['ROS1', 'SIRT1']",0.9951480220574164,0,0,2
326,BMP Signaling Pathway in Eyelid Development WP3927,0.6297745403400916,0.9501180637544274,0.43932831821839713,"['SMAD4', 'MAP3K1', 'INHBB']",0.9951480220574164,0,0,3
327,Complement Activation WP545,0.6297745403400916,0.9501180637544274,0.43932831821839713,"['C3', 'C1QA', 'MASP2']",0.9951480220574164,0,0,3
328,MFAP5 effect on permeability and motility of endothelial cells via cytoskeleton rearrangement WP4560,0.6297745403400916,0.9501180637544274,0.43932831821839713,"['ACTN1', 'ITPR1', 'PTK2']",0.9951480220574164,0,0,3
329,Endoplasmic reticulum stress response in coronavirus infection WP4861,0.6298424391626939,0.9333163885913472,0.4314587149701984,"['PPP1R3G', 'PPP1R3F', 'MAPK8', 'PPP1R13B', 'PPP1R1B', 'PPP1R9A', 'PPP1R12B', 'ATF6']",0.9951480220574164,0,0,8
330,Hypothesized Pathways in Pathogenesis of Cardiovascular Disease WP3668,0.6339229055576987,0.9334082709356927,0.4254735618574649,"['SMAD2', 'MAPK8', 'POSTN', 'SMAD4']",0.9951480220574164,0,0,4
331,The Overlap Between Signal Transduction Pathways that Contribute to a Range of LMNA Laminopathies WP4879,0.6367203992117587,0.9278491983244258,0.4188540028567198,"['RB1', 'SMAD2', 'CEBPA', 'TGFB2', 'MAOA', 'HDAC1', 'AGO2', 'DICER1', 'LEMD3']",0.9951480220574164,0,0,9
332,Benzene metabolism WP3891,0.6383151669779196,1.108568479008947,0.4976620264085103,['EPHX1'],0.9951480220574164,0,0,1
333,Composition of Lipid Particles WP3601,0.6383151669779196,1.108568479008947,0.4976620264085103,['LCAT'],0.9951480220574164,0,0,1
334,Linoleic acid metabolism known to be affected by coronavirus infection WP4853,0.6383151669779196,1.108568479008947,0.4976620264085103,['ACOT2'],0.9951480220574164,0,0,1
335,Robo4 and VEGF Signaling Pathways Crosstalk WP3943,0.6383151669779196,1.108568479008947,0.4976620264085103,['SLIT2'],0.9951480220574164,0,0,1
336,Somatroph axis (GH) and its relationship to dietary restriction and aging WP4186,0.6383151669779196,1.108568479008947,0.4976620264085103,['SIRT1'],0.9951480220574164,0,0,1
337,The alternative pathway of fetal androgen synthesis WP4524,0.6383151669779196,1.108568479008947,0.4976620264085103,['HSD17B6'],0.9951480220574164,0,0,1
338,Epithelial to mesenchymal transition in colorectal cancer WP4239,0.6401221840696268,0.9412761411877377,0.4198997174916834,"['NOTCH2', 'SMAD2', 'TGFB2', 'SMAD4', 'SPARC', 'JUP', 'TUSC3', 'EED', 'NUBPL', 'FZD7', 'EIF5A2', 'FZD6', 'PIK3CB', 'LRP6', 'CLDN11', 'CLDN20', 'MAPK8', 'CLDN9', 'AKT2', 'COL4A5', 'SNAI2', 'KRAS', 'RAF1', 'MAP2K6']",0.9951480220574164,0,0,24
339,Bladder cancer WP2828,0.6443726169770818,0.9172342474057698,0.4031043848604467,"['RB1', 'CCND1', 'MYC', 'KRAS', 'RAF1', 'HBEGF']",0.9951480220574164,0,0,6
340,EGFR Tyrosine Kinase Inhibitor Resistance WP4806,0.6473399848132733,0.9261779591499811,0.4027796455444232,"['SHC2', 'RPS6', 'RRAS2', 'PIK3CB', 'NRG2', 'IGF1', 'CCND1', 'RPS6KB1', 'MYC', 'AKT2', 'NF1', 'KRAS', 'RAF1', 'EIF4E']",0.9951480220574164,0,0,14
341,G Protein Signaling Pathways WP35,0.6532996127168205,0.9233805901337022,0.39310105845513355,"['PDE1C', 'PRKCE', 'ITPR1', 'GNAI3', 'AKAP6', 'GNAI1', 'ADCY5', 'AKAP13', 'PPP3CA', 'AKAP10', 'PPP3CC', 'GNAQ', 'KRAS', 'PRKD1', 'KCNJ3']",0.9951480220574164,0,0,15
342,TYROBP causal network in microglia WP3945,0.6551669288812739,0.9093144408770487,0.38451745342086463,"['C3', 'FKBP15', 'KCNE3', 'RGS1', 'IL18', 'TNFRSF1B', 'ZFP36L2', 'IL13RA1']",0.9951480220574164,0,0,8
343,Non-small cell lung cancer WP4255,0.6552741454424256,0.9170627121672325,0.3876438649590794,"['RB1', 'RXRA', 'CDK6', 'CCND1', 'CRABP2', 'AKT2', 'RARB', 'KRAS', 'PIK3CB', 'POLK', 'RAF1', 'FHIT']",0.9951480220574164,0,0,12
344,Modulators of TCR signaling and T cell activation WP5072,0.660425415419169,0.9066911349520045,0.37615993291363214,"['IKBKB', 'CDKN1B', 'CHUK', 'RASA2', 'ARIH2', 'CBLB', 'MAP3K8', 'MAP3K14', 'MALT1']",0.9951480220574164,0,0,9
345,Canonical and non-canonical Notch signaling WP3845,0.6687210013067214,0.8866689631415777,0.3567852559711794,"['NOTCH2', 'CHUK', 'MAML1', 'DNER']",0.9951480220574164,0,0,4
346,Physiological and pathological hypertrophy of the heart WP1528,0.6687210013067214,0.8866689631415777,0.3567852559711794,"['PPP3CA', 'MAPK8', 'MYEF2', 'PRKCE']",0.9951480220574164,0,0,4
347,Host-pathogen interaction of human coronaviruses - autophagy WP4863,0.6699114943847949,0.8867079889807162,0.3552237977390209,"['PIK3R4', 'ATG10', 'ATG7']",0.9951480220574164,0,0,3
348,Kynurenine Pathway and links to Cellular Senescence WP5044,0.6699114943847949,0.8867079889807162,0.3552237977390209,"['KLF5', 'EIF2AK4', 'NOS1']",0.9951480220574164,0,0,3
349,Methionine De Novo and Salvage Pathway WP3580,0.6699114943847949,0.8867079889807162,0.3552237977390209,"['MSRA', 'AHCY', 'MSRB3']",0.9951480220574164,0,0,3
350,Nanomaterial induced apoptosis WP2507,0.6699114943847949,0.8867079889807162,0.3552237977390209,"['ENDOG', 'APAF1', 'HTRA2']",0.9951480220574164,0,0,3
351,TCA Cycle (aka Krebs or citric acid cycle) WP78,0.6699114943847949,0.8867079889807162,0.3552237977390209,"['OGDH', 'DLST', 'IDH3A']",0.9951480220574164,0,0,3
352,Kisspeptin/kisspeptin receptor system in the ovary WP4871,0.6726464827913019,0.8865908307480179,0.3515646257230051,"['AKT2', 'PRKCE', 'ARRB1', 'KRAS', 'PIK3CB', 'RAF1']",0.9951480220574164,0,0,6
353,Eukaryotic Transcription Initiation WP405,0.6758717975551077,0.886551724137931,0.34730829534999635,"['GTF2B', 'POLR2C', 'ILK', 'POLR3H', 'TAF6', 'MNAT1', 'GTF2E1']",0.9951480220574164,0,0,7
354,Iron metabolism in placenta WP2007,0.6771944175686059,0.8867469879518072,0.3456512022995711,"['TF', 'ACO1']",0.9951480220574164,0,0,2
355,MFAP5-mediated ovarian cancer cell motility and invasiveness WP3301,0.6771944175686059,0.8867469879518072,0.3456512022995711,"['RYR3', 'PTK2']",0.9951480220574164,0,0,2
356,LncRNA involvement in canonical Wnt signaling and colorectal cancer WP4258,0.6986542566750077,0.8863165169315825,0.3178324690423818,"['CTBP2', 'RYK', 'CHD8', 'SERPINF1', 'FZD7', 'FZD6', 'LRP6', 'CCND3', 'CDK6', 'CCND1', 'MYC', 'DVL2', 'MAP3K7']",0.9951480220574164,0,0,13
357,The influence of laminopathies on Wnt signaling WP4844,0.6993197308040093,0.8524624927105975,0.3048808488493812,"['CEBPA', 'CDK6', 'CCND1', 'AGO2', 'DICER1']",0.9951480220574164,0,0,5
358,IL-5 signaling pathway WP127,0.6994371264540747,0.8579244087133469,0.3066902792537405,"['GSK3A', 'RPS6KB1', 'MYC', 'RPS6', 'KRAS', 'RAF1']",0.9951480220574164,0,0,6
359,IL-3 signaling pathway WP286,0.7006907579863628,0.8618582375478927,0.3065531786803357,"['HCK', 'MAPK8', 'FYN', 'ENPP3', 'GAB2', 'RAF1', 'CBL']",0.9951480220574164,0,0,7
360,Interleukin-11 Signaling Pathway WP2332,0.7006907579863628,0.8618582375478927,0.3065531786803357,"['IKBKB', 'YES1', 'CHUK', 'RPS6KB1', 'RPS6', 'FYN', 'RAF1']",0.9951480220574164,0,0,7
361,Netrin-UNC5B signaling pathway WP4747,0.7006907579863628,0.8618582375478927,0.3065531786803357,"['ARHGEF12', 'PPP2R1B', 'NTN4', 'FYN', 'RAF1', 'RLF', 'PTK2']",0.9951480220574164,0,0,7
362,Photodynamic therapy-induced AP-1 survival signaling. WP3611,0.7006907579863628,0.8618582375478927,0.3065531786803357,"['RB1', 'MAPK8', 'CCND1', 'CCNE1', 'MAP2K7', 'HBEGF', 'MAP2K6']",0.9951480220574164,0,0,7
363,Glycosylation and related congenital defects WP4521,0.7011707702500959,0.8443810179945213,0.29975848027736596,"['DPAGT1', 'TUSC3', 'MOGS', 'DOLK']",0.9951480220574164,0,0,4
364,Monoamine Transport WP727,0.7011707702500959,0.8443810179945213,0.29975848027736596,"['HRH3', 'ADORA2A', 'NOS1', 'SLC6A1']",0.9951480220574164,0,0,4
365,Control of immune tolerance by vasoactive intestinal peptide WP4484,0.7048940960468657,0.8867859600825877,0.3101158836600917,['IL5'],0.9951480220574164,0,0,1
366,Eicosanoid metabolism via cytochrome P450 monooxygenases (CYP) pathway WP4720,0.7048940960468657,0.8867859600825877,0.3101158836600917,['PPARA'],0.9951480220574164,0,0,1
367,Fatty Acid Omega Oxidation WP206,0.7048940960468657,0.8867859600825877,0.3101158836600917,['ALDH1A1'],0.9951480220574164,0,0,1
368,Fluoroacetic acid toxicity WP4966,0.7048940960468657,0.8867859600825877,0.3101158836600917,['ALDH3A2'],0.9951480220574164,0,0,1
369,SARS-CoV-2 and COVID-19 Pathway WP4846,0.7048940960468657,0.8867859600825877,0.3101158836600917,['NRP1'],0.9951480220574164,0,0,1
370,Somatic sex determination WP4814,0.7048940960468657,0.8867859600825877,0.3101158836600917,['SOX9'],0.9951480220574164,0,0,1
371,Endochondral Ossification with Skeletal Dysplasias WP4808,0.7050247605227186,0.8671347556035647,0.30308298229521263,"['GHR', 'HDAC4', 'TGFB2', 'CHST11', 'FGF18', 'CTSV', 'SOX9', 'IGF1', 'BMPR1A']",0.9951480220574164,0,0,9
372,Endochondral Ossification WP474,0.7050247605227186,0.8671347556035647,0.30308298229521263,"['GHR', 'HDAC4', 'TGFB2', 'CHST11', 'FGF18', 'CTSV', 'SOX9', 'IGF1', 'BMPR1A']",0.9951480220574164,0,0,9
373,B Cell Receptor Signaling Pathway WP23,0.7062072741638793,0.886237897648686,0.30827474653128034,"['GSK3A', 'CHUK', 'NFATC3', 'GAB2', 'CBL', 'MALT1', 'IKBKB', 'MAPK8', 'MYC', 'BLNK', 'FYN', 'RAF1', 'MAP3K7', 'GTF2I', 'MAP2K6']",0.9951480220574164,0,0,15
374,Hereditary leiomyomatosis and renal cell carcinoma pathway WP4206,0.7067553122334875,0.831224173553719,0.2884936106425798,"['EGLN1', 'PRKAA1', 'RPS6']",0.9951480220574164,0,0,3
375,miRNA targets in ECM and membrane receptors WP2911,0.7067553122334875,0.831224173553719,0.2884936106425798,"['ITGB5', 'LAMA4', 'COL6A1']",0.9951480220574164,0,0,3
376,PI3K/AKT/mTOR - VitD3 signaling WP4141,0.7067553122334875,0.831224173553719,0.2884936106425798,"['PFKFB4', 'RXRA', 'MYC']",0.9951480220574164,0,0,3
377,Pathways Regulating Hippo Signaling WP4540,0.7196207703200057,0.8737262844262255,0.2874829576187813,"['SMAD2', 'PRKAA1', 'PRKCE', 'INSR', 'GNAI3', 'PRKAG2', 'YY1AP1', 'CDH6', 'LATS1', 'CDH20', 'GNAQ', 'CDH10', 'KIT', 'CDH12']",0.9951480220574164,0,0,14
378,Amplification and Expansion of Oncogenic Pathways as Metastatic Traits WP3678,0.7205978994662262,0.8060710373963386,0.2641285176024168,"['POSTN', 'EPAS1']",0.9951480220574164,0,0,2
379,Cysteine and methionine catabolism WP4504,0.7205978994662262,0.8060710373963386,0.2641285176024168,"['MPST', 'AHCY']",0.9951480220574164,0,0,2
380,FOXA2 pathway WP5066,0.7205978994662262,0.8060710373963386,0.2641285176024168,"['MLXIPL', 'IRS2']",0.9951480220574164,0,0,2
381,GPR40 Pathway WP3958,0.7205978994662262,0.8060710373963386,0.2641285176024168,"['PLCL1', 'PLCH1']",0.9951480220574164,0,0,2
382,H19 action Rb-E2F1 signaling and CDK-Beta-catenin activity WP3969,0.7205978994662262,0.8060710373963386,0.2641285176024168,"['RB1', 'CCND1']",0.9951480220574164,0,0,2
383,Hedgehog Signaling Pathway Netpath WP47,0.7205978994662262,0.8060710373963386,0.2641285176024168,"['SUFU', 'ARNTL']",0.9951480220574164,0,0,2
384,Major receptors targeted by epinephrine and norepinephrine WP4589,0.7205978994662262,0.8060710373963386,0.2641285176024168,"['ADRA2A', 'ADCY5']",0.9951480220574164,0,0,2
385,Omega-3/Omega-6 FA synthesis WP4723,0.7205978994662262,0.8060710373963386,0.2641285176024168,"['ACOT2', 'ACSL4']",0.9951480220574164,0,0,2
386,Prostaglandin Synthesis and Regulation WP98,0.7247118153771714,0.8310496380558429,0.2675823590405211,"['ANXA4', 'ANXA5', 'SCGB1A1', 'MITF', 'SOX9', 'PPARGC1A']",0.9951480220574164,0,0,6
387,22q11.2 copy number variation syndrome WP4657,0.7258007712877385,0.8751894982726298,0.28048048669342507,"['PRKN', 'OAT', 'COMT', 'RTN4', 'MALT1', 'ARNTL', 'ACTA2', 'HIRA', 'ARVCF', 'NCOR1', 'THAP7', 'DGCR6L', 'DROSHA', 'RAF1', 'TNPO1', 'KPNB1']",0.9951480220574164,0,0,16
388,BDNF-TrkB Signaling WP3676,0.7267234320132888,0.8208259948439135,0.26201528915812405,"['TRPC6', 'RPS6KB1', 'MKNK1', 'KRAS', 'GAB2']",0.9951480220574164,0,0,5
389,Melatonin metabolism and effects WP3298,0.7267234320132888,0.8208259948439135,0.26201528915812405,"['MAOA', 'MAP2', 'CRY1', 'SIRT1', 'ARNTL']",0.9951480220574164,0,0,5
390,FGFR3 signaling in chondrocyte proliferation and terminal differentiation WP4767,0.7312583253528543,0.8059374314971972,0.252249144073234,"['RBL1', 'FGF18', 'SOX9', 'RAF1']",0.9951480220574164,0,0,4
391,SARS-CoV-2 mitochondrial interactions WP5038,0.7312583253528543,0.8059374314971972,0.252249144073234,"['NDUFB9', 'DDX58', 'TRAF3', 'IKBKE']",0.9951480220574164,0,0,4
392,FBXL10 enhancement of MAP/ERK signaling in diffuse large B-cell lymphoma WP4553,0.7403546546011649,0.7822678658240155,0.23517001610858446,"['EED', 'H3F3A', 'BCOR']",0.9951480220574164,0,0,3
393,Metabolism of Spingolipids in ER and Golgi apparatus WP4142,0.7403546546011649,0.7822678658240155,0.23517001610858446,"['UGT8', 'GALNT1', 'SGPP2']",0.9951480220574164,0,0,3
394,One-carbon metabolism WP241,0.7403546546011649,0.7822678658240155,0.23517001610858446,"['AHCYL2', 'DNMT1', 'AHCY']",0.9951480220574164,0,0,3
395,Photodynamic therapy-induced NF-kB survival signaling WP3617,0.7403546546011649,0.7822678658240155,0.23517001610858446,"['IKBKB', 'CCND1', 'CHUK']",0.9951480220574164,0,0,3
396,Purine metabolism and related disorders WP4224,0.7403546546011649,0.7822678658240155,0.23517001610858446,"['PFAS', 'PAICS', 'ADA']",0.9951480220574164,0,0,3
397,Pathogenic Escherichia coli infection WP2272,0.7456596310736078,0.8244703466311559,0.24197053837554758,"['ITGB1', 'TUBA1B', 'ROCK1', 'ABL1', 'FYN', 'CD14', 'TUBB4B', 'TUBA8']",0.9951480220574164,0,0,8
398,RAC1/PAK1/p38/MMP2 Pathway WP3303,0.7463015771241146,0.8360633316182648,0.24465345177535938,"['ITGB1', 'IKBKB', 'GRB7', 'MAPK8', 'CHUK', 'MYC', 'RASA1', 'KRAS', 'NOS1', 'PTK2']",0.9951480220574164,0,0,10
399,ncRNAs involved in Wnt signaling in hepatocellular carcinoma WP4336,0.7473408284404247,0.8403505429605639,0.2447385953496255,"['CCND3', 'CCND1', 'CTBP2', 'RYK', 'CHD8', 'MYC', 'SERPINF1', 'FZD7', 'FZD6', 'DVL2', 'LRP6']",0.9951480220574164,0,0,11
400,PDGF Pathway WP2526,0.7484583464536412,0.8058036413775814,0.23347332628790132,"['TIAM1', 'MAPK8', 'MAP3K1', 'CHUK', 'RASA1', 'RAF1']",0.9951480220574164,0,0,6
401,Disruption of postsynaptic signaling by CNV WP4875,0.7522768732164393,0.7914492468248499,0.22528669318420064,"['GRIN2A', 'DLG2', 'DLGAP1', 'GRIN2B', 'GRM1']",0.9951480220574164,0,0,5
402,Airway smooth muscle cell contraction WP4962,0.7589643519718134,0.7388410786001147,0.20377271657699497,"['ROCK1', 'GNAQ']",0.9951480220574164,0,0,2
403,Fatty acid transporters WP5061,0.7589643519718134,0.7388410786001147,0.20377271657699497,"['ACSL5', 'ACSL4']",0.9951480220574164,0,0,2
404,Galanin receptor pathway WP4970,0.7589643519718134,0.7388410786001147,0.20377271657699497,"['CDKN1B', 'PPARGC1A']",0.9951480220574164,0,0,2
405,Kennedy pathway from sphingolipids WP3933,0.7589643519718134,0.7388410786001147,0.20377271657699497,"['CHPT1', 'CEPT1']",0.9951480220574164,0,0,2
406,miR-509-3p alteration of YAP1/ECM axis WP3967,0.7589643519718134,0.7388410786001147,0.20377271657699497,"['SPARC', 'SNAI2']",0.9951480220574164,0,0,2
407,Benzo(a)pyrene metabolism WP696,0.759220563435982,0.7389309474650149,0.20354809596702095,['EPHX1'],0.9951480220574164,0,0,1
408,Disorders of the Krebs cycle WP4236,0.759220563435982,0.7389309474650149,0.20354809596702095,['DLST'],0.9951480220574164,0,0,1
409,Dual hijack model of Vif in HIV infection WP3300,0.759220563435982,0.7389309474650149,0.20354809596702095,['RUNX1'],0.9951480220574164,0,0,1
410,Folate-Alcohol and Cancer Pathway Hypotheses WP1589,0.759220563435982,0.7389309474650149,0.20354809596702095,['ALDH1A1'],0.9951480220574164,0,0,1
411,Ketogenesis and Ketolysis WP4742,0.759220563435982,0.7389309474650149,0.20354809596702095,['SLC25A20'],0.9951480220574164,0,0,1
412,LDLRAD4 and what we know about it WP4904,0.759220563435982,0.7389309474650149,0.20354809596702095,['SMAD2'],0.9951480220574164,0,0,1
413,Nucleotide GPCRs WP80,0.759220563435982,0.7389309474650149,0.20354809596702095,['ADORA2A'],0.9951480220574164,0,0,1
414,Tgif disruption of Shh signaling WP3674,0.759220563435982,0.7389309474650149,0.20354809596702095,['SMAD2'],0.9951480220574164,0,0,1
415,Ebola Virus Pathway on Host WP4217,0.7601225330388963,0.8573342712625197,0.235145898241131,"['ITGB1', 'VPS18', 'TSG101', 'GSN', 'CAV3', 'ITGA3', 'DDX58', 'ACTN1', 'VPS4A', 'PIK3CB', 'TIAM1', 'RASA2', 'RAB9A', 'FLNB', 'TOP1', 'MFGE8', 'IKBKE', 'CTSB']",0.9951480220574164,0,0,18
416,Male infertility WP4673,0.7701451507909558,0.8437350727215825,0.22036358285631402,"['SLC46A1', 'PACRG', 'CCNT2', 'INSR', 'HMGA1', 'CXXC1', 'CHD2', 'MLH3', 'ARNTL', 'ABLIM1', 'AGO2', 'SLC16A7', 'ATM', 'NOS1', 'RGS9', 'RAG1']",0.9951480220574164,0,0,16
417,Nephrotic syndrome WP4758,0.7706824546102728,0.782042703327453,0.20370558556349513,"['SMARCAL1', 'TRPC6', 'ITGA3', 'PTPRO', 'COL4A5', 'GPC5']",0.9951480220574164,0,0,6
418,Angiogenesis WP1539,0.7708156097933687,0.738751147842057,0.19230142368533157,"['TIMP2', 'ARNT', 'PTK2']",0.9951480220574164,0,0,3
419,Differentiation of white and brown adipocyte WP2895,0.7708156097933687,0.738751147842057,0.19230142368533157,"['CEBPA', 'PRDM16', 'PPARGC1A']",0.9951480220574164,0,0,3
420,Glycerolipids and Glycerophospholipids WP4722,0.7708156097933687,0.738751147842057,0.19230142368533157,"['GPAM', 'CHPT1', 'AGPAT4']",0.9951480220574164,0,0,3
421,Pregnane X receptor pathway WP2876,0.7708156097933687,0.738751147842057,0.19230142368533157,"['RXRA', 'CYP3A5', 'PPARGC1A']",0.9951480220574164,0,0,3
422,Vitamin D Receptor Pathway WP2877,0.7752249788555889,0.8500132908027644,0.21641508085488398,"['CEBPA', 'TGFB2', 'CDKN1B', 'HILPDA', 'CLEC16A', 'CDKAL1', 'MYO9B', 'TRAK1', 'CYP3A5', 'CRACR2A', 'RXRA', 'CCND1', 'CCNE1', 'CLMN', 'MYC', 'DNER', 'TIMP2', 'SOSTDC1', 'CD14']",0.9951480220574164,0,0,19
423,Microglia Pathogen Phagocytosis Pathway WP3937,0.7760019340857165,0.7640984814277906,0.1937755784638975,"['C1QA', 'HCK', 'FCER1G', 'RAC3', 'PIK3CB']",0.9951480220574164,0,0,5
424,Signaling of Hepatocyte Growth Factor Receptor WP313,0.7760019340857165,0.7640984814277906,0.1937755784638975,"['ITGB1', 'MAPK8', 'RASA1', 'RAF1', 'PTK2']",0.9951480220574164,0,0,5
425,Parkin-Ubiquitin Proteasomal System pathway WP2359,0.7812855380106976,0.8055355069507641,0.19881791613015262,"['PRKN', 'TUBA1B', 'CCNE1', 'CUL1', 'CASK', 'UBE2L6', 'UBE2G1', 'STUB1', 'TUBB4B', 'TUBA8']",0.9951480220574164,0,0,10
426,Aryl Hydrocarbon Receptor Pathway WP2873,0.7844828006728739,0.7386611551268802,0.17929568826771233,"['CDKN1B', 'AIP', 'ARNT', 'POLK']",0.9951480220574164,0,0,4
427,Endothelin Pathways WP2197,0.7844828006728739,0.7386611551268802,0.17929568826771233,"['ATP2A2', 'RAF1', 'ADRA1A', 'GNAI1']",0.9951480220574164,0,0,4
428,Hair Follicle Development: Organogenesis - Part 2 of 3 WP2839,0.7844828006728739,0.7386611551268802,0.17929568826771233,"['ITGB1', 'CCND1', 'MYC', 'NCAM1']",0.9951480220574164,0,0,4
429,PDGFR-beta pathway WP3972,0.7844828006728739,0.7386611551268802,0.17929568826771233,"['MAPK8', 'MAP3K1', 'RASA1', 'RAF1']",0.9951480220574164,0,0,4
430,Focal Adhesion WP306,0.7864623573687458,0.8680747238067976,0.20852059275709853,"['ITGB1', 'SHC2', 'ITGB5', 'ROCK1', 'LAMA4', 'ITGA2B', 'LAMA3', 'ILK', 'PIK3CB', 'ARHGAP5', 'MYLK4', 'CCND3', 'MAPK8', 'CCND1', 'AKT2', 'CAPN2', 'RAC3', 'FLNB', 'FYN', 'PAK3', 'CAV3', 'ITGA3', 'ACTN1', 'VEGFD', 'IGF1', 'PTK2', 'HCK', 'RAF1', 'PPP1R12B', 'ITGA9']",0.9951480220574164,0,0,30
431,Biomarkers for pyrimidine metabolism disorders WP4584,0.792677171179795,0.6819541903879254,0.1584447171967049,"['DPYS', 'CKB']",0.9951480220574164,0,0,2
432,Blood Clotting Cascade WP272,0.792677171179795,0.6819541903879254,0.1584447171967049,"['F7', 'F8A1']",0.9951480220574164,0,0,2
433,Extracellular vesicles in the crosstalk of cardiac cells WP4300,0.792677171179795,0.6819541903879254,0.1584447171967049,"['SORBS2', 'IGF1']",0.9951480220574164,0,0,2
434,Mitochondrial complex III assembly WP4921,0.792677171179795,0.6819541903879254,0.1584447171967049,"['UQCC3', 'CYC1']",0.9951480220574164,0,0,2
435,Regulation of Wnt/B-catenin Signaling by Small Molecule Compounds WP3664,0.792677171179795,0.6819541903879254,0.1584447171967049,"['FZD7', 'DVL2']",0.9951480220574164,0,0,2
436,Renin-angiotensin-aldosterone system (RAAS) WP4756,0.7979401229472778,0.7385711003905353,0.1667115378285908,"['CREB3', 'CAMK1D', 'GNAQ', 'ITPR1', 'CAMK1G']",0.9951480220574164,0,0,5
437,Estrogen signaling pathway WP712,0.7982855830490925,0.699815137016094,0.1576605628679396,"['IKBKB', 'CHUK', 'SP1']",0.9951480220574164,0,0,3
438,Fatty Acid Biosynthesis WP357,0.7982855830490925,0.699815137016094,0.1576605628679396,"['ACLY', 'ACSL5', 'ACSL4']",0.9951480220574164,0,0,3
439,NAD+ biosynthetic pathways WP3645,0.7982855830490925,0.699815137016094,0.1576605628679396,"['TNKS2', 'NADSYN1', 'SIRT1']",0.9951480220574164,0,0,3
440,Aspirin and miRNAs WP4707,0.8035487425047025,0.6333202241667486,0.13851817364166905,['PPARA'],0.9951480220574164,0,0,1
441,Classical pathway of steroidogenesis with glucocorticoid and mineralocorticoid metabolism WP4523,0.8035487425047025,0.6333202241667486,0.13851817364166905,['H6PD'],0.9951480220574164,0,0,1
442,Disorders of Folate Metabolism and Transport WP4259,0.8035487425047025,0.6333202241667486,0.13851817364166905,['SLC46A1'],0.9951480220574164,0,0,1
443,HIF1A and PPARG regulation of glycolysis WP2456,0.8035487425047025,0.6333202241667486,0.13851817364166905,['GAPDH'],0.9951480220574164,0,0,1
444,Liver X receptor pathway WP2874,0.8035487425047025,0.6333202241667486,0.13851817364166905,['RXRA'],0.9951480220574164,0,0,1
445,Macrophage markers WP4146,0.8035487425047025,0.6333202241667486,0.13851817364166905,['CD14'],0.9951480220574164,0,0,1
446,Methylation Pathways WP704,0.8035487425047025,0.6333202241667486,0.13851817364166905,['COMT'],0.9951480220574164,0,0,1
447,NAD Biosynthesis II (from tryptophan) WP2485,0.8035487425047025,0.6333202241667486,0.13851817364166905,['NADSYN1'],0.9951480220574164,0,0,1
448,IL-4 signaling pathway WP395,0.8053959843382478,0.7564592094196804,0.16371382233480303,"['IKBKB', 'CEBPA', 'CHUK', 'RPS6KB1', 'IRS2', 'GAB2', 'CBL']",0.9951480220574164,0,0,7
449,Osteoblast differentiation WP4787,0.8093616535844423,0.8144499178981938,0.1722638330196648,"['NOTCH2', 'SMAD4', 'BMPR2', 'PRKCE', 'FZD7', 'FZD6', 'PIK3R4', 'PIK3CB', 'PIK3C2B', 'LRP6', 'MAPK8', 'FGF18', 'SOX9', 'PRKD1', 'MAPK6', 'BMPR1A']",0.9951480220574164,0,0,16
450,Folate Metabolism WP176,0.8106608088351006,0.7384809835688843,0.15501125741479832,"['F7', 'SLC46A1', 'AHCY', 'RFK', 'INSR', 'NOS1']",0.9951480220574164,0,0,6
451,Notch Signaling WP268,0.8106608088351006,0.7384809835688843,0.15501125741479832,"['NOTCH2', 'CTBP2', 'HDAC1', 'MAML1', 'DVL2', 'DTX2']",0.9951480220574164,0,0,6
452,mBDNF and proBDNF regulation of GABA neurotransmission WP4829,0.8181487434712404,0.7146906471621352,0.14344636090689095,"['GABRB3', 'GABRB2', 'ROCK1', 'AP2A1', 'PIK3CB']",0.9951480220574164,0,0,5
453,Cancer immunotherapy by PD-1 blockade WP4585,0.8221492527444975,0.633194000491763,0.12400048821270068,"['CD8B', 'NFATC3']",0.9951480220574164,0,0,2
454,Glycosaminoglycan degradation WP4815,0.8221492527444975,0.633194000491763,0.12400048821270068,"['GLB1', 'ARSB']",0.9951480220574164,0,0,2
455,Sudden Infant Death Syndrome (SIDS) Susceptibility Pathways WP706,0.8227310122741763,0.8198950595902449,0.15998281862959057,"['CHRM2', 'CHRNB2', 'ADCYAP1R1', 'CAV3', 'MAOA', 'HDAC1', 'SLC1A3', 'ATP1A3', 'CTCF', 'PBX1', 'MECP2', 'HADHB', 'TF', 'MAP2', 'SP1', 'BHLHE40', 'NOS1AP', 'PPARGC1A', 'GAPDH', 'SPTBN1']",0.9951480220574164,0,0,20
456,miRNA regulation of p53 pathway in prostate cancer WP3982,0.822939942444815,0.6647727272727273,0.12954562741236736,"['APAF1', 'SHISA5', 'ATM']",0.9951480220574164,0,0,3
457,Trans-sulfuration and one-carbon metabolism WP2525,0.822939942444815,0.6647727272727273,0.12954562741236736,"['AHCYL2', 'DNMT1', 'AHCY']",0.9951480220574164,0,0,3
458,Fibrin Complement Receptor 3 Signaling Pathway WP4136,0.8289439464597993,0.6817350751212273,0.12789536939911123,"['IKBKB', 'CHUK', 'CBLB', 'CD14']",0.9951480220574164,0,0,4
459,Overview of leukocyte-intrinsic Hippo pathway functions WP4542,0.8289439464597993,0.6817350751212273,0.12789536939911123,"['LATS1', 'FYB1', 'STK38L', 'FOXO4']",0.9951480220574164,0,0,4
460,Endometrial cancer WP4155,0.8298174567974247,0.7521973514590413,0.14032206535262373,"['CCND1', 'MYC', 'AKT2', 'ILK', 'KRAS', 'PIK3CB', 'POLK', 'CTNNA2', 'RAF1']",0.9951480220574164,0,0,9
461,Nonalcoholic fatty liver disease WP4396,0.8334563678601702,0.8154794470583945,0.1485590926546957,"['COX8A', 'MLXIP', 'CEBPA', 'NDUFB9', 'GSK3A', 'PRKAA1', 'INSR', 'PRKAG2', 'IRS2', 'PIK3CB', 'ADIPOR1', 'IKBKB', 'MLXIPL', 'MAPK8', 'ITCH', 'RXRA', 'AKT2', 'NDUFS4', 'MLX', 'CYC1', 'PPARA']",0.9951480220574164,0,0,21
462,Thyroid hormones production and their peripheral downstream signaling effects WP4746,0.8361785995072823,0.7702034992866261,0.13779945944247735,"['RPTOR', 'CREB3', 'RPS6KA6', 'NHSL1', 'RXRA', 'TG', 'RPS6KB1', 'RPS6', 'ZNF516', 'PRDM16', 'RAF1', 'PPARGC1A']",0.9951480220574164,0,0,12
463,15q11.2 copy number variation syndrome WP4940,0.83971820685032,0.5541121816930489,0.09679725384784812,['TUBGCP3'],0.9951480220574164,0,0,1
464,ATR Signaling WP3875,0.83971820685032,0.5541121816930489,0.09679725384784812,['RAD9A'],0.9951480220574164,0,0,1
465,Bile acids synthesis and enterohepatic circulation  WP4389,0.83971820685032,0.5541121816930489,0.09679725384784812,['SLC10A1'],0.9951480220574164,0,0,1
466,"Degradation pathway of sphingolipids, including diseases WP4153",0.83971820685032,0.5541121816930489,0.09679725384784812,['GLB1'],0.9951480220574164,0,0,1
467,IL-10 Anti-inflammatory Signaling Pathway  WP4495,0.83971820685032,0.5541121816930489,0.09679725384784812,['BLVRB'],0.9951480220574164,0,0,1
468,Mammary gland development pathway - Involution (Stage 4 of 4) WP2815,0.83971820685032,0.5541121816930489,0.09679725384784812,['MYC'],0.9951480220574164,0,0,1
469,Role of Osx and miRNAs in tooth development WP3971,0.83971820685032,0.5541121816930489,0.09679725384784812,['NOTCH2'],0.9951480220574164,0,0,1
470,Small Ligand GPCRs WP247,0.83971820685032,0.5541121816930489,0.09679725384784812,['CNR1'],0.9951480220574164,0,0,1
471,Somitogenesis in the context of spondylocostal dysostosis WP4785,0.83971820685032,0.5541121816930489,0.09679725384784812,['TBX6'],0.9951480220574164,0,0,1
472,Tamoxifen metabolism WP691,0.83971820685032,0.5541121816930489,0.09679725384784812,['CYP3A5'],0.9951480220574164,0,0,1
473,Nuclear Receptors in Lipid Metabolism and Toxicity WP299,0.844971177079855,0.6330676898858717,0.10664200100273595,"['ABCD3', 'RARB', 'PPARA']",0.9951480220574164,0,0,3
474,"Oligodendrocyte specification and differentiation, leading to myelin components for CNS WP4304",0.844971177079855,0.6330676898858717,0.10664200100273595,"['SOX9', 'IGF1', 'MYT1']",0.9951480220574164,0,0,3
475,Type I interferon induction and signaling during SARS-CoV-2 infection WP4868,0.844971177079855,0.6330676898858717,0.10664200100273595,"['DDX58', 'TRAF3', 'IKBKE']",0.9951480220574164,0,0,3
476,FGF23 signaling in hypophosphatemic rickets and related disorders WP4790,0.8477991612731847,0.5909351692484223,0.09757019772972865,"['CCND1', 'ROS1']",0.9951480220574164,0,0,2
477,Pyrimidine metabolism and related diseases WP4225,0.8477991612731847,0.5909351692484223,0.09757019772972865,"['CPS1', 'DPYS']",0.9951480220574164,0,0,2
478,miRNA regulation of prostate cancer signaling pathways WP3981,0.8481474977280918,0.656434595118715,0.10811525196876312,"['CDKN1B', 'CCND1', 'KRAS', 'RAF1']",0.9951480220574164,0,0,4
479,Neovascularisation processes WP4331,0.8481474977280918,0.656434595118715,0.10811525196876312,"['SMAD2', 'MAPK8', 'TGFB2', 'KIT']",0.9951480220574164,0,0,4
480,Pyrimidine metabolism WP4022,0.848191510497644,0.7591413767579571,0.12499174012301159,"['POLA1', 'PNPT1', 'NME7', 'DPYS', 'POLR2C', 'POLR1C', 'NME3', 'CMPK2', 'CTPS1', 'POLR3H', 'TK1', 'ENPP3']",0.9951480220574164,0,0,12
481,Translation Factors WP107,0.853205475764283,0.704717868338558,0.11187739673998272,"['EIF4A2', 'EEF1G', 'EIF1AY', 'EEF2', 'EIF4E', 'PAIP1', 'EIF4G1']",0.9951480220574164,0,0,7
482,Vitamin A and carotenoid metabolism WP716,0.853664883526271,0.6712716412923166,0.10620629679445724,"['RXRA', 'CRABP2', 'RDH12', 'ALDH1A1', 'RARB']",0.9951480220574164,0,0,5
483,Cannabinoid receptor signaling WP3869,0.8645802805935133,0.6042449286250939,0.08792435302981168,"['MAPK8', 'ADORA2A', 'CNR1']",0.9951480220574164,0,0,3
484,Ovarian infertility WP34,0.8645802805935133,0.6042449286250939,0.08792435302981168,"['CDKN1B', 'NCOR1', 'ATM']",0.9951480220574164,0,0,3
485,Photodynamic therapy-induced unfolded protein response WP3613,0.8645802805935133,0.6042449286250939,0.08792435302981168,"['EDEM1', 'UBE2E1', 'ATF6']",0.9951480220574164,0,0,3
486,Striated Muscle Contraction Pathway WP383,0.8645802805935133,0.6042449286250939,0.08792435302981168,"['ACTA2', 'TNNT2', 'DMD']",0.9951480220574164,0,0,3
487,Cytokines and Inflammatory Response WP530,0.8692301644793063,0.4925059264357268,0.06902338935569181,['IL5'],0.9951480220574164,0,0,1
488,Gene regulatory network modelling somitogenesis  WP2854,0.8692301644793063,0.4925059264357268,0.06902338935569181,['TBX6'],0.9951480220574164,0,0,1
489,Non-homologous end joining WP438,0.8692301644793063,0.4925059264357268,0.06902338935569181,['NHEJ1'],0.9951480220574164,0,0,1
490,TCA cycle in senescence WP5050,0.8692301644793063,0.4925059264357268,0.06902338935569181,['ME1'],0.9951480220574164,0,0,1
491,Apoptosis Modulation by HSP70 WP384,0.870035066285303,0.5539586919104992,0.07712310520216788,"['MAP3K1', 'APAF1']",0.9951480220574164,0,0,2
492,Nuclear receptors WP170,0.8811098417601293,0.6110682171831755,0.07734472664728977,"['RXRA', 'NR1H2', 'RARB', 'PPARA']",0.9951480220574164,0,0,4
493,Pre-implantation embryo WP3527,0.8811098417601293,0.6110682171831755,0.07734472664728977,"['HMGA1', 'ATP1A1', 'ZFP36L2', 'PBX1']",0.9951480220574164,0,0,4
494,White fat cell differentiation WP4149,0.8819700578981821,0.5779284944304707,0.07258618423713872,"['CEBPA', 'KLF5', 'KLF15']",0.9951480220574164,0,0,3
495,Copper homeostasis WP3286,0.8832012186748252,0.6328148075219061,0.07859700623394814,"['CCND1', 'SCO2', 'SP1', 'COX17', 'COMMD1']",0.9951480220574164,0,0,5
496,DNA Replication WP466,0.8832012186748252,0.6328148075219061,0.07859700623394814,"['ORC5', 'POLA1', 'ORC2', 'MCM3', 'MCM2']",0.9951480220574164,0,0,5
497,NO/cGMP/PKG mediated Neuroprotection WP4008,0.8832012186748252,0.6328148075219061,0.07859700623394814,"['GRIN2A', 'PDE2A', 'TSPO', 'NOS1', 'GRIN2B']",0.9951480220574164,0,0,5
498,p53 transcriptional gene network WP4963,0.8850407194526827,0.6812959375912119,0.08320096656283214,"['TIGAR', 'APAF1', 'CCNG1', 'ERCC5', 'POLK', 'ACAD11', 'CPT1C', 'CX3CL1']",0.9951480220574164,0,0,8
499,Inflammatory Response Pathway WP453,0.889244396041401,0.5213323883770375,0.06119564840614548,"['IL5', 'TNFRSF1B']",0.9951480220574164,0,0,2
500,RAS and bradykinin pathways in COVID-19 WP4969,0.889244396041401,0.5213323883770375,0.06119564840614548,"['ROCK1', 'NOS1']",0.9951480220574164,0,0,2
501,Prader-Willi and Angelman Syndrome WP3998,0.8910195582027509,0.6595818048422597,0.07610841951927133,"['GABRB3', 'RB1', 'HERC2', 'CDK6', 'CCND1', 'GNRH1', 'MDM4']",0.9951480220574164,0,0,7
502,Corticotropin-releasing hormone signaling pathway WP2355,0.8925170862364176,0.7057760829529987,0.08025353109337927,"['GRK3', 'MAPK8', 'JUP', 'SP1', 'GNAQ', 'IL18', 'ARRB1', 'RAF1', 'RAPGEF3', 'GNAI1', 'PTK2']",0.9951480220574164,0,0,11
503,Biomarkers for urea cycle disorders WP4583,0.8933096781612375,0.44322092222986925,0.05000505943773479,['F7'],0.9951480220574164,0,0,1
504,"Metabolic pathway of LDL, HDL and TG, including diseases WP4522",0.8933096781612375,0.44322092222986925,0.05000505943773479,['LCAT'],0.9951480220574164,0,0,1
505,Purine metabolism WP4792,0.8933096781612375,0.44322092222986925,0.05000505943773479,['ADA'],0.9951480220574164,0,0,1
506,Hepatitis C and Hepatocellular Carcinoma WP3646,0.8959506254999327,0.6151887587104679,0.0675907723059738,"['UCHL1', 'MAPK8', 'SMAD4', 'CCND1', 'MYC']",0.9951480220574164,0,0,5
507,ESC Pluripotency Pathways WP3931,0.9013629635385647,0.7204881068175789,0.07482071379537117,"['SMAD4', 'BMPR2', 'FZD7', 'FZD6', 'LRP6', 'FGF17', 'AKT2', 'FGF18', 'DVL2', 'FGF20', 'RAF1', 'MAPK6', 'MAP2K6', 'BMPR1A']",0.9951480220574164,0,0,14
508,Chemokine signaling pathway WP3929,0.9020469729073897,0.744344484234431,0.07673349323413667,"['SHC2', 'CHUK', 'ROCK1', 'GNAI3', 'ARRB1', 'PIK3CB', 'PTK2', 'CX3CL1', 'GNAI1', 'ADCY5', 'TIAM2', 'IKBKB', 'TIAM1', 'HCK', 'AKT2', 'CSK', 'KRAS', 'RAF1']",0.9951480220574164,0,0,18
509,IL-18 signaling pathway WP4754,0.907588928662116,0.7928996096941091,0.07688249941204996,"['SPON1', 'PRKAA1', 'PIGT', 'STOML1', 'TSHZ1', 'MEPCE', 'ITGA2B', 'COX17', 'ENO1', 'FUT1', 'RPTOR', 'IKBKB', 'GRM7', 'LONP2', 'TRPM7', 'LRRFIP1', 'MAP2K7', 'MAP3K7', 'ZNF143', 'SLC12A3', 'CHUK', 'IMP3', 'IL18', 'EEF2', 'GRIN2B', 'ACTA2', 'TF', 'RPS6KB1', 'SP1', 'ZNF219', 'NFKBIE', 'SNTB1', 'ARF6']",0.9951480220574164,0,0,33
510,Metapathway biotransformation Phase I and II WP702,0.9102244118092133,0.7302684180468304,0.06869204405052355,"['CHST8', 'CHST6', 'GSTP1', 'EPHX1', 'KCNAB1', 'COMT', 'CYP7B1', 'NAT14', 'CYP3A5', 'HS3ST4', 'HS2ST1', 'CYP27A1', 'CYP2U1', 'CHST11', 'CYP4V2', 'CHST2', 'SULT1C4']",0.9951480220574164,0,0,17
511,BMP2-WNT4-FOXO1 pathway in primary endometrial stromal cell differentiation WP3876,0.9129564474247632,0.4028968278796221,0.0366906466151066,['DCN'],0.9951480220574164,0,0,1
512,Cancer immunotherapy by CTLA4 blockade WP4582,0.9129564474247632,0.4028968278796221,0.0366906466151066,['PIK3CB'],0.9951480220574164,0,0,1
513,Drug Induction of Bile Acid Pathway WP2289,0.9129564474247632,0.4028968278796221,0.0366906466151066,['SLC10A1'],0.9951480220574164,0,0,1
514,Osteoclast Signaling WP12,0.9129564474247632,0.4028968278796221,0.0366906466151066,['MAPK8'],0.9951480220574164,0,0,1
515,Platelet-mediated interactions with vascular and circulating cells WP4462,0.9129564474247632,0.4028968278796221,0.0366906466151066,['TGFB2'],0.9951480220574164,0,0,1
516,Serotonin and anxiety-related events WP3944,0.9129564474247632,0.4028968278796221,0.0366906466151066,['PPP3CA'],0.9951480220574164,0,0,1
517,Mitochondrial complex I assembly model OXPHOS system WP4324,0.9185699060207847,0.6038356679514901,0.05128815215439017,"['NDUFB9', 'NUBPL', 'NDUFAF4', 'NDUFS4', 'NDUFAF2', 'TMEM70']",0.9951480220574164,0,0,6
518,Eicosanoid Synthesis WP167,0.919995178693956,0.46638282453120755,0.03889019439988888,"['PTGES2', 'ALOX5AP']",0.9951480220574164,0,0,2
519,Kallmann's Syndrome WP5074,0.919995178693956,0.46638282453120755,0.03889019439988888,"['PLXND1', 'GNRH1']",0.9951480220574164,0,0,2
520,Statin inhibition of cholesterol production WP430,0.919995178693956,0.46638282453120755,0.03889019439988888,"['SQLE', 'LCAT']",0.9951480220574164,0,0,2
521,NRF2 pathway WP2884,0.9202725544717226,0.7060563255937141,0.05866297078939072,"['TGFB2', 'SRXN1', 'GSTP1', 'SLC39A12', 'SLC5A2', 'SLC6A1', 'AGER', 'SLC39A14', 'SLC6A7', 'RXRA', 'SLC39A6', 'ME1', 'BLVRB', 'FTL', 'HBEGF']",0.9951480220574164,0,0,15
522,Complement and Coagulation Cascades WP558,0.9272162287701813,0.5677340119104419,0.04290279866462234,"['C3', 'F7', 'C1QA', 'F2R', 'MASP2']",0.9951480220574164,0,0,5
523,Nucleotide Excision Repair WP4753,0.9272162287701813,0.5677340119104419,0.04290279866462234,"['CUL4A', 'XPA', 'ERCC5', 'ERCC6', 'MNAT1']",0.9951480220574164,0,0,5
524,SARS-CoV-2 innate immunity evasion and cell-specific immune response WP5039,0.9272162287701813,0.5677340119104419,0.04290279866462234,"['AP1G1', 'DDX58', 'TRAF3', 'TRADD', 'CXCL17']",0.9951480220574164,0,0,5
525,Lung fibrosis WP3624,0.9288116808726665,0.5368323260159292,0.03964467666199592,"['MECP2', 'RTEL1', 'IL5', 'IGF1']",0.9951480220574164,0,0,4
526,Cori Cycle WP1946,0.9289862553666987,0.36929341592108283,0.027202646157153433,['GAPDH'],0.9951480220574164,0,0,1
527,Ganglio Sphingolipid Metabolism WP1423,0.9289862553666987,0.36929341592108283,0.027202646157153433,['FUT1'],0.9951480220574164,0,0,1
528,Glutathione metabolism WP100,0.9289862553666987,0.36929341592108283,0.027202646157153433,['IDH1'],0.9951480220574164,0,0,1
529,Regulatory circuits of the STAT3 signaling pathway WP4538,0.9300941760925323,0.6212910683054653,0.04502461166310532,"['GHR', 'RPTOR', 'PTPRD', 'CNTFR', 'MAPK8', 'CSF3R', 'F2R', 'MAPK6']",0.9951480220574164,0,0,8
530,Fluoropyrimidine Activity WP1601,0.9332079534893741,0.49215641261095805,0.03402140266882803,"['DPYS', 'FPGS', 'TK1']",0.996595663537709,0,0,3
531,"Non-genomic actions of 1,25 dihydroxyvitamin D3 WP4341",0.9357488339122345,0.5959283819628647,0.03957451827409731,"['IKBKB', 'IFI27L2', 'MAPK8', 'RXRA', 'SP1', 'PRKCE', 'KRAS']",0.9966517259335174,0,0,7
532,Hematopoietic Stem Cell Differentiation WP2849,0.9376524452345851,0.5210026139287958,0.03354002577564412,"['HMGN5', 'IL5', 'ITGA2B', 'RUNX1']",0.9966517259335174,0,0,4
533,Pathways of nucleic acid metabolism and innate immune sensing WP4705,0.9420647939477593,0.34085975964847265,0.020342927459290942,['DDX58'],0.9966517259335174,0,0,1
534,Phytochemical activity on NRF2 transcriptional activation WP3,0.9420647939477593,0.34085975964847265,0.020342927459290942,['MAPK8'],0.9966517259335174,0,0,1
535,Riboflavin and CoQ disorders WP5037,0.9420647939477593,0.34085975964847265,0.020342927459290942,['RFK'],0.9966517259335174,0,0,1
536,TGF-beta receptor signaling in skeletal dysplasias WP4816,0.949824862481578,0.5270585146532769,0.02713174253060024,"['SMAD2', 'FKBP1A', 'SMAD4', 'ZFYVE9', 'ADAMTS10']",0.9966744966926004,0,0,5
537,Alpha 6 Beta 4 signaling pathway WP244,0.9502691933946678,0.4581433456825306,0.023369879720314943,"['LAMA3', 'IRS2', 'PTK2']",0.9966744966926004,0,0,3
538,Cholesterol Biosynthesis Pathway WP197,0.952735271071946,0.31648805427194965,0.01532378150791995,['SQLE'],0.9966744966926004,0,0,1
539,Dopaminergic Neurogenesis WP2855,0.952735271071946,0.31648805427194965,0.01532378150791995,['ALDH1A1'],0.9966744966926004,0,0,1
540,Tryptophan catabolism leading to NAD+ production WP4210,0.952735271071946,0.31648805427194965,0.01532378150791995,['NADSYN1'],0.9966744966926004,0,0,1
541,Photodynamic therapy-induced HIF-1 survival signaling WP3614,0.957185088937188,0.4428374655647383,0.019377903618453308,"['EGLN1', 'PKM', 'ARNT']",0.9966744966926004,0,0,3
542,IL-6 signaling pathway WP364,0.9585058795928945,0.4786474383443037,0.020284878532175806,"['HCK', 'RPS6KB1', 'HDAC1', 'MAP3K7']",0.9966744966926004,0,0,4
543,NAD+ metabolism WP3644,0.9614409403050134,0.2953659096122964,0.011614419761133189,['SIRT1'],0.9966744966926004,0,0,1
544,Gastric Cancer Network 2 WP2363,0.9654126340690473,0.3690763052208835,0.012991363767138293,"['MYC', 'LBR']",0.9966744966926004,0,0,2
545,Oxidative Stress WP408,0.9654126340690473,0.3690763052208835,0.012991363767138293,"['MAOA', 'SP1']",0.9966744966926004,0,0,2
546,DNA Repair Pathways Full Network WP4946,0.9656351151147136,0.6376675710181934,0.022298752723163142,"['MRE11', 'XPA', 'FANCB', 'CUL4A', 'RAD52', 'BRIP1', 'RAD50', 'USP1', 'ATM', 'ERCC5', 'POLK', 'ERCC6', 'MNAT1', 'NHEJ1', 'FAN1']",0.9966744966926004,0,0,15
547,Allograft Rejection WP2328,0.9658610636529884,0.4918064170304005,0.01708303436847524,"['C3', 'C1QA', 'TUBA1B', 'IL5', 'LRRK2']",0.9966744966926004,0,0,5
548,Oncostatin M Signaling Pathway WP2374,0.968386931139336,0.510619680216371,0.016402916482130925,"['MAPK8', 'CDKN1B', 'PRKCE', 'RPS6', 'KRAS', 'RAF1']",0.9966744966926004,0,0,6
549,TGF-beta Receptor Signaling WP560,0.9685961996910705,0.45403075509861596,0.014486973845065492,"['SMAD2', 'FKBP1A', 'SMAD4', 'ZFYVE9']",0.9966744966926004,0,0,4
550,Differentiation Pathway WP2848,0.9729004374877768,0.4024855997996494,0.011057699124785691,"['TF', 'KIT', 'IGF1']",0.9966744966926004,0,0,3
551,Interactions between immune cells and microRNAs in tumor microenvironment WP4559,0.974338040549665,0.26057649487874984,0.006774199667439448,['TGFB2'],0.9966744966926004,0,0,1
552,Nucleotide metabolism WP404,0.974338040549665,0.26057649487874984,0.006774199667439448,['POLA1'],0.9966744966926004,0,0,1
553,Myometrial relaxation and contraction pathways WP289,0.9754800027438139,0.6312901631240732,0.015672168830089206,"['RGS17', 'PRKCE', 'ITPR1', 'ATP2A2', 'ARRB1', 'RXFP2', 'RYR3', 'ADCY5', 'ACTA2', 'CREB3', 'RGS1', 'SP1', 'GNAQ', 'PRKD1', 'NOS1', 'RGS9', 'RGS6']",0.9966744966926004,0,0,17
554,Selenium Micronutrient Network WP15,0.9772301990104224,0.507648388920294,0.011692683852518527,"['PRDX3', 'F7', 'SELENOS', 'RFK', 'INSR', 'ALOX5AP', 'SELENOT']",0.9966744966926004,0,0,7
555,Host-pathogen interaction of human coronaviruses - apoptosis WP4864,0.9790654066450278,0.2460809054064388,0.0052062916446253705,['APAF1'],0.9966744966926004,0,0,1
556,Serotonin Receptor 4/6/7 and NR3C Signaling WP734,0.9790654066450278,0.2460809054064388,0.0052062916446253705,['MAPKAPK2'],0.9966744966926004,0,0,1
557,Globo Sphingolipid Metabolism WP1424,0.9829220742919612,0.23311116745752888,0.004015441340286888,['FUT1'],0.9988041185803412,0,0,1
558,Complement system WP2806,0.9877134663715633,0.4690073145245559,0.0057981672221944286,"['C3', 'FCGR3A', 'RPS19', 'ITGA2B', 'GNAI3', 'MASP2', 'DCN']",0.9992276063828073,0,0,7
559,Eicosanoid metabolism via lipooxygenases (LOX) WP4721,0.9886350875872298,0.21087733097368336,0.0024103250547934446,['PPARA'],0.9992276063828073,0,0,1
560,Unfolded protein response WP4925,0.9886350875872298,0.21087733097368336,0.0024103250547934446,['ATF6'],0.9992276063828073,0,0,1
561,One-carbon metabolism and related pathways WP3940,0.9923842297785371,0.3237502519653296,0.0024750442206229574,"['GAD2', 'CHPT1', 'CEPT1']",0.9999003666302234,0,0,3
562,Vitamin B12 metabolism WP1533,0.9928339329437907,0.26823136702654776,0.001929084221125145,"['F7', 'INSR']",0.9999003666302234,0,0,2
563,Type II interferon signaling (IFNG) WP619,0.9958944009293906,0.1702578220128117,0.0007004492235798404,['IRF2'],0.9999105402169187,0,0,1
564,Oxidative phosphorylation WP623,0.9976033872279845,0.27638601928374656,0.000663185280791018,"['NDUFB9', 'NDUFS4', 'ATP5F1D']",0.9999105402169187,0,0,3
565,Electron Transport Chain (OXPHOS system in mitochondria) WP111,0.9994969852865627,0.32305092440789973,0.0001625402516638186,"['COX8A', 'NDUFB9', 'SURF1', 'COX17', 'NDUFS4', 'ATP5F1D']",0.9999105402169187,0,0,6
566,Proteasome Degradation WP183,0.9999105402169187,0.15500196273817074,1.386706224516833e-05,"['UCHL1', 'PSMB10']",0.9999105402169187,0,0,2
